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MONITORING THE EFFECTS OF PSYCHOTROPIC DRUGS
IN STUDENTS WITH EMOTIONAL IMPAIRMENTS:
HOME AND SCHOOL DATA
Lynne E. Turner, Ph.D.
Western Michigan University, 2004

Research has shown that schools do not typically participate in the systematic
monitoring of psychotropic medications prescribed to school-aged children with
emotional disorders. Conversely, research indicates that the information that is
relayed to the prescribing physician from the schools consists, in general, of informal
global reports regarding the student's overall behavior. Additionally, research
evaluating systematic monitoring systems within schools has lacked input from the
prescribing physician regarding relevant data to be collected. These findings provided
impetus for the present project, which was an attempt to develop a practical system
for schools to monitor possible desired and adverse effects of psychotropic
medications.
For this project input from parents/guardians, teachers, and an interested
psychiatrist was used to select procedures for measvuing these effects. Possible
desired effects in several behavioral domains were assessed using the Nisonger Child
Behavior Rating Form (CBRF) -Parent and -Teacher scales, whereas side effects were
evaluated using the Detection of Side Effect Seale (DOSES). Data intended to reflect
the status of students at home and at school were obtained monthly from
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parents/guardians and teachers, respectively. Parents/guardians and teachers were
surveyed concerning their satisfaction with this monitoring system and the results
obtained were conveyed to the participating psychiatrist. Finally, information was
obtained regarding the medication monitoring process prior to the onset of the present
study.
The results of the parent/guardian and teacher acceptability surveys indicate
that both the Nisonger CBRF scales and the DOSES were easy to understand. And at
the end of the present study, the School Social Worker was familiar enough with the
N-CBRF scales and the DOSES to report these data to the prescribing psychiatrist
directly. A key issue in evaluating the effects of psychotropic medications in school
settings is developing procedures that yield clinically meaningful data without unduly
burdening school personnel. To that end, the monitoring system developed for the
present study indicates a positive step in that direction.
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INTRODUCTION

Overview of Serious Emotional Disturbance

"Serious emotional disturbance” (SED) is one of the most ambiguous labels
that can be assigned to a student with special needs. In the field of child psychiatry,
the SED diagnosis originated with studies investigating drug effects in adolescents
with emotional impairments during the 1950s and 1960s (Conners, Eisenberg, &
Sharpe, 1964; Freed & Peifer, 1956). The term SED referred to heterogeneous groups
of children and adolescents who were housed in psychiatric hospitals or residential
facilities (Conners et al.) or who were outpatients in a psychiatric or child guidance
clinic (Freed & Peifer). Although the children examined often were diagnosed with a
specific psychiatric disorder (e.g., primary behavior disorder, psychoneurotic,
schizophrenic, reactive behavior disorder with organic brain disease), not everyone
agreed as to the disorders SED should comprise (Freed & Peifer). Moreover, some of
the participants (subjects) in these early drug studies did not have a psychiatric
diagnosis.
In education, the term SED gained popularity with the passage of the
Education for All Handicapped Children Act of 1975 (EAHCA), Public Law (PL) 94142, the justly-famous federal statute which dictates that all students have the right to
a free and appropriate public education. Such an education may include special
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education services, and the law specified the conditions that make a student eligible
for these services. One of these is SED:
The term seriously emotionally disturbed [SED] means a condition exhibiting
one or more of the following characteristics over a long period of time and to
a marked degree, which adversely affects educational performance: (a) an
inability to learn which cannot be explained by intellectual, sensory, or health
factors; (b) an inability to build or maintain satisfactory interpersonal
relationships with peers and teachers; (c) inappropriate types of behavior or
feelings under normal circumstances; (d) a general pervasive mood of
unhappiness or depression; or (e) a tendency to develop physical symptoms or
fears associated with personal or school problems. The term includes children
who are schizophrenic or autistic. The term does not include children who are
socially maladjusted, unless it is determined that they are seriously
emotionally disturbed (Federal Register, 1977, p. 42478)
As defined, SED involves a variety of behaviors that adversely affect the
student’s educational performance. That is, the PL 94-142 definition of SED is not
based on the student having a psychiatric diagnosis, but rather the student’s behavior
displayed in the school setting. Although students given the educational diagnosis of
SED may display behaviors that meet the diagnostic criteria for a psychiatric
disorder, such a diagnosis is not a requirement for the special education label.
Since the initial passage of PL 94-142, several amendments to this law have
occurred (Yell, 1998). Two significant changes that occurred in the 1990 amendment.
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P.L. 101-476, were the changing of the name of the law to the Individuals with
Disabilities Education Act (IDEA) and the changing of the language to emphasize the
person

first,

e.g.,

changing

the

term

“handicapped

student”

to

“child/student/individual with a disability” (Yell, 1998). The federal label referring to
a student with SED, however, was not changed until recently. The 1997
reauthorization of IDEA included a provision to drop the term “serious” from the
terminology (Fomes & Kavale, 2000). Thus the federal label became a student with
an “emotional disturbance” (ED) (34 CFR 300.74). The ED definition itself remains
unchanged. Although ED is the federal term, this label is not used by all states. For
example, ED is not recognized in Michigan where the present study was conducted.
The participants in this study received the educational diagnosis of “emotional
impairment,” (El) which is similar to the federal label of ED.
It is estimated that approximately 1% of all school-aged children are identified
as ED (U.S. Department of Education, 2002). Most of these students are treated with
non-pharmacological interventions. That is, the educational plan to deal with their
special needs involves using strategies such as positive reinforcement, response cost,
self-monitoring, and a highly structured classroom environment (Miltenberger, 2001;
O’Neill et al., 1997; Paine, Radicchi, Rosellini, Deutchman, & Darch, 1983; Shapiro,
Duman, Post, & Levinson, 2002). For example, many of the students labeled as ED
could be classified as having social competence deficits (Gresham, 2002). In this
case, the interventions utilized would be structured to teach the students necessary
skills to cope better with social situations. Because ED comprises students with a
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wide range of behavioral problems and a huge range of specific interventions have
been used, it is impossible to make meaningful summary statements regarding the
general effectiveness of non-pharmacological interventions in this population. It is,
however, clear that such interventions have proven useful in treating a wide range of
specific

problems

(Miltenberger; O’Neil et al.; Paine et al.; Shapiro et al.).

Pharmacological Treatment of Emotional Disturbance

Rationale for Pharmacological Interventions

Many students labeled as ED also have a DSM-IV Axis I diagnosis (e.g.,
conduct disorder, oppositional defiant disorder, bipolar disorder, anxiety disorder,
depression, schizophrenia) (Gadow, 1986; Mattison, Spitznagel, & Felix, 1998).
Depending on the nature and severity of the psychiatric comorbidity, these children
may be prime candidates for pharmacotherapy (Epstein & Olinger, 1987; Wilson &
Sherrets, 1979). For example, depression is among the most conunon of psychiatric
disorders in adolescents, and drugs are often and effectively used to treat the disorder
(e.g., Julien, 2001; Lewinsohn, Hops, Roberts, Seeley, & Andrews, 1993).
Drug therapy is the most common medical intervention for behaviors
displayed by students with ED (Cullinan, Epstein, & Lloyd, 1983; Mundo,
Pumariega, & Vance, 1999). Several studies have examined the kinds of drugs that
such students receive and the prevalence of their use (Brovra, Dingle, & Landau,
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1994; Cullinan, Gadow, & Epstein, 1987; Epstein, Cullinan, & Gadow, 1985; Epstein
& Olinger, 1987; Fomess, Kavale, Sweeney, & Crenshaw, 1999; Gadow, 1986;
Hallfors, Fallon, & Watson, 1998; Mundo et al; Wilson & Sherrets, 1979). Results
indicate that 11-30% of students classified as ED receive one or more drugs intended
to improve behavior.
Several authors have summarized the kinds of medications typically
prescribed for students, including those with ED (Brown et al., 1994; Fomess et al.,
1999; Gadow, 1986; Mundo et al., 1999; Shreeram & Kruesi, 1999). These authors
also summarize for various drug classes (e.g., stimulants, antidepressants,
anxiolytics), and some individual dmgs: (a) desired effects, (b) adverse effects, (c)
behaviors and psychiatric diagnoses for which they are commonly prescribed, and (d)
dosage information.
As with nonpharmacological interventions, it is impossible to summarize the
effectiveness of drag treatments because of the vast range of drags used and
conditions treated. It is worth noting, however, that some of the psychiatric conditions
that commonly accompany an educational label of ED, such as autism and cognitive
impairment, generally are not treated effectively with drags (Matson et al., 2000;
Poling, Laraway, Ehrhardt, Jennings, & Turner, in press). No drags are approved for
treating these conditions, therefore pharmacological interventions in such cases are
for off-label purposes.
When a medication is used to treat a condition for which it has not been
approved, it is said to be an off-label use of the medication. That is, the FDA has not
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approved the medication for treatment of the condition in question. For example, a
child may be prescribed clonidine (Catapres) to target hyperactive and noncompliant
behaviors, however, this medication is only FDA-approved for use in the treatment of
hypertension. When physicians prescribe a psychotropic medication for an off-label
use they are in essence conducting a mini-experiment. TTiat is, the physician is
h)q>othesizing that administering a specific drug will produce a desired effect without
producing a significant adverse reaction (Sprague & Werry, 1971). In such cases, it is
essential that sufficient data be collected to confirm or reject this hypothesis. These
data should accurately reflect elements of behavior targeted by the prescribing
physician and other relevant caregivers for improvement, as well as side effects.
There is nothing wrong with the off-label use of medications, which is
common in medicine. In fact, when well-controlled research indicates that off-label
applications are generally effective and no on-label altemative medications are
available, using drugs for applications not approved by the Food and Drug
Administration is consistent with medical best practices (Hardman, Limbird,
Molinoff, Ruddon, & Gilman, 1995).
Even in such cases, however, it can never be assumed that any given
individual will respond favorably to a particular medication. Therefore, careful
monitoring is required to ensure that a) the medication that an individual receives is
actually beneficial, and b) the medication is used to benefit that individual to the
maximum extent possible (Gadow & Poling, 1988; Poling & Ehrhardt, 1999). The
same is true when medications are prescribed for off-label conditions for which there
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is no clear evidence of effectiveness. As noted, this is the case with respect to some of
the psychiatric conditions for which students with ED receive psychotropic
medications. Under these circumstances, an especially compelling case can be made
for careful monitoring of drug effects. As Poling et al. (in press) point out with
respect to the use of psychotropic drugs to treat behavioral problems in people with
developmental disabilities:
At present, because of the absence of relevant outcome data, it is almost
impossible to know a priori whether a given medication will positively affect
the behavior of a person with a developmental disability. Therefore, drug
effects should be carefully monitored in any such person who receives a
psychotropic medication. Unfortunately, however, this appears to occur rarely.
The result is that many people with developmental disabilities receive
medications that affect them in unknown ways. Given that medications are
relatively restrictive interventions, this is unfortunate. Enhanced monitoring of
drug effects is an essential step in improving the pharmaceutical treatment of
behavior disorders in people with developmental disabilities. Despite
arguments to the contrary, such drugs are not “bad” or “good.” Some people
with developmental disabilities derive benefits from drug treatment that
cannot be produced by other kinds of interventions. Other people, however,
are exposed to unnecessary and even harmfiil drug regimens. Appropriate
drug treatment requires that the right people receive medication, and that their
medication regimen is managed to produce optimal benefit. Careful drug
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monitoring helps to achieve both ends. At present, our best advice for anyone
concerned with the pharmaceutical treatment of behavior disorders in people
with developmental disabilities is simple: Be skeptical and collect data.
Essentially the same argument can be made with respect to the pharmacological
treatment of students diagnosed with ED.

Importance of Svstematicallv Monitoring Psvchotropic Medication

Judicious monitoring of the efficacy of psychotropic medications prescribed
for school-aged children is important for several reasons in addition to those noted
previously. First, and foremost, the vast majority of research on the effectiveness of
psychotropic medication has focused on adults. The effects of psychotropic
medication in children often differ from those reported for adults (Barkley et al.,
1990; Taylor, 1994).
Second, there is not a specific psychotropic medication treatment for specific
behaviors (e.g., crying, acting out, noncompliance), which are often targeted in
students with ED, and few indicators accurately predict children’s responses to
specific medication or dosages (Taylor). Therefore, careful monitoring of children’s
responses to the different drugs and different dosage levels is essential for identifying
the most effective treatment. Moreover, in many cases, when physicians prescribe
medications to deal with behavioral problems in school-aged children, the drugs are
prescribed for off-label usage, as discussed previously.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Third, children are constantly changing as they mature, making monitoring of
medication effects imperative (Brown & Sawyer, 1998; Zametkin & Yamada, 1993).
That is, drug effects may vary with development (Brown & Sawyer; Zametkin &
Yamada). Fourth, children are less capable than adults of reporting the presence of
adverse effects (Brown & Sawyer; Zametkin & Yamada). Customarily, adults will
inform their physician when a medication is causing problems or is not producing the
desired effects. Even in adults, however, the approach of asking people about how
they have benefited from a medication does not accurately evaluate the degree of
change because, “people simply do not remember how they were in the beginning”
(Streiner & Norman, 1995, p. 165). Finally, decisions to prescribe psychotropic
medications or change dosage levels typically are based on informal global
assessments provided by parents or teachers (Brown & Sawyer; Fredericks & Hayes,
1995; Gadow, 1982, 1983; Singh & Winton, 1984). Children’s actual behavior may
have little influence on these decisions.
The need for monitoring medication effects in school-aged individuals has
been emphasized by professionals for many decades. In 1971, the Report of the
Conference on Stimulant Drugs stated:
The decision to use drug treatment depends on the commitment to diagnose
and to monitor the response to the treatment in the best traditions of medical
practice. When there is informed parental consent, parents, teachers and
professionals can collaborate in organizing and monitoring treatment
programs, (as cited in Weithom & Ross, 1975, p. 60).
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This report emphasized the need for input from multiple sources for adequate
monitoring of the medication. That is, all of the adult individuals who have an impact
on the medication process (i.e., parents, teachers, physicians) should systematically
work together to provide the child with the best medical treatment. Clearly, adequate
monitoring of the effects of psychotropic drugs is necessary to optimize treatment for
individual students (Poling, 1994).

Svstematic Monitoring Procedures

An effective medication monitoring system may involve any of a variety of
assessment strategies intended to quantify desired behavioral effects of psychotropic
medications. These include imstructured, semistructured, and structured interviews,
and symptom checklists (Aman, 1993; Brown & Sawyer, 1998; Kazdin, 1982;
Miltenberger, 2001; O’Neill et al., 1997). Even though they appear to be a common
tool for indexing drug effects (Brown & Sawyer), there is little research regarding
unstructured interviews, although their psychometric characteristics have been
questioned (Young, O’Brien, Gutterman, & Cohen, 1987). Structured interviews and
instructions for conducting and scoring them have become more readily available in
recent years (Brown & Sawyer). Such interviews usually consist of a series of
questions, observations, or tests that must be carried out exactly as specified (Aman;
Kazdin; Miltenberger; O’Neill et al.).
The structured interview is not an ideal technique for monitoring medications.
Problems with structured interviews include their questionable sensitivity and
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specificity in identifying individual symptoms of disorders and the substantial time
required to master and to administer them (Brown & Sawyer, 1998). Semistructured
interviews also require significant training on the part of the interviewer. Moreover,
they require the interviewer to make judgment calls and interpret responses of the
interviewee, and therefore characteristically are relatively weak in terms of reliability
and validity (Aman, 1993; Brown & Sawyer; Heijanic & Reich, 1982). The use of
symptom checklists, which provide the interviewer with a list of questions concerning
whether or not particular signs and symptoms occurred during the period of interest,
may increase the value of semistructured interviews (Aman; Brown & Sawyer).
A behavior rating scale is another means for systematically monitoring
medication. In general, rating scales have a number of features that make them
attractive for assessing the effects of psychotropic medications. They are economical
in that most individuals can complete them in a few minutes (Aman, 1993; Brown &
Sawyer, 1998). They enable raters to aggregate behaviors across a wide range of
settings and over time (Aman; Brown & Sawyer). Thus, infrequent behaviors can be
detected and recorded. They tend to be clinically relevant and consumer-oriented
(Aman; Brown & Sawyer). The better ones provide norms by which to determine
how “abnormal” the problem behavior is (Aman; Brown & Sawyer). Finally, many of
them have been shown to be highly sensitive to pharmacological treatment (Aman;
Brown & Sawyer; Campbell, Green, & Deutsch, 1985).
Rating scales do have some general limitations. There is the possibility of
rater subjectivity in determining whether a given behavior constitutes a problem
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(Aman, 1993; Brown & Sawyer, 1998). There also is a tendency for raters to score
children with extreme behavior as less severe over successive ratings (Achenbach &
Edelbrock, 1986)). This has been characterized as regression to the mean (Milich,
Roberts, Loney, Caputo, 1980) and is most likely to occur from the first to the second
rating (Aman). In some cases, there is a tendency for raters to score the child in terms
of the rater’s overall impression, regardless of the content of various items and their
contribution to different domains or subscales (Aman). Finally, although raters are
generally acceptably reliable in evaluating acting-out problems and disorders (e.g.,
aggression, conduct disorder), they are less reliable in evaluating internalizing or
emotional problems (e.g., anxiety, depression) (Hodges, 1990).
There are many types of rating scales available to monitor the effects of
medications. These scales fall into two categories, general rating scales and scales for
a specific diagnosis, symptom, or problem behavior. One of the best-known general
rating scales is the Clinical Global Impressions (CGI; “Rating Scales,” 1985). The
purpose of the CGI is to formalize and quantify the usual way judgments of drug
efficacy are made by physicians and others by integrating all information from a
multitude of sources (e.g. physician’s reports, parent’s reports, teacher’s reports).
The information is recorded onto three subscales: (a) Severity of Illness, which is
rated at each assessment; (b) Global Improvement, which is scored only after
treatment has begun; and (c) Efficacy Index, which is rated on a two-way scale in
which Therapeutic Effect is assessed against Side Effects (“Rating Scales”). A serious
limitation of the CGI is that its psychometric characteristics are unknown, and
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probably vary across clinical population, physicians, and types of drags (Aman,
1993). In addition, criteria for rating particular domains are somewhat ambiguous.
Another general rating scale, and one that has been rather carefully studied, is
the Child Behavior Checklist (CBCL; Achenbach, 1991a). The CBCL is a 132-item
rating form designed as a parent-rating instrument for assessing children. It consists
of two sections. Social Competence and Problem Behavior, which are scored on a 3point scale. The Social Competence section contains 20 items on amount and quality
of the child’s involvement in sports, hobbies, organizations, jobs, friendships, etc.
The Problem Behavior section contains 112 items describing externalizing and
internalizing problem behaviors (Achenbach). The research evaluating the CBCL
indicates that it has a high test-retest agreement and a high interrater agreement.
Additionally, research has shown that the CBCL has good content validity,
moderately high convergent validity, and satisfactory-to-good criterion-group validity
(Achenbach). The research is limited, however, in that it has not focused on assessing
drag effects (Achenbach; Aman, 1993). That is, the CBCL’s drag sensitivity is
largely unknown.
Rating scales that assess a specific diagnosis, symptom, or problem behavior
have been developed to quantify attention deficit hyperactivity disorder (ADHD),
conduct, oppositional, and aggressive problems, depression, and anxiety. There are
many ADHD rating scales available, including the Childhood Attention Problems
(CAP; Edelbrock, 1978), the Conners Abbreviated Symptom Questionnaire (CASQ;
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Goyette, Conners, «fe Ulrich, 1978), and the Attention Deficit Hyperactivity Disorder
(ADHD) Rating Scale (DuPaul, 1991).
The CAP was adapted from the Conners Teacher Rating Form (TRF;
Achenbach, 1991b) by extracting items that consistently loaded heavily on the
Hyperactivity factor of the CTRF and that were consistent with DSM-III-R criteria
for ADHD (Edelbrock, 1978). It is a 12-item instrument that is easy to administer. It
consists of two subscales, inattention and hyperactivity and there are no age
differences for norms. Research suggests that this scale is reliable, valid, and drug
sensitive (Edelbrock).
The CASQ uses 10 main items describing inattention and disruptive behaviors
common to both Conners Teacher Rating Scale and Conners Parent Rating Scale
(Goyette et al., 1978). Research indicates that this scale is not very sensitive to the
effects of medications (Aman, 1993). Finally, the ADHD Rating Scale is a 14-item
instrument based on the symptoms specified in the DSM-III-R (DuPaul, 1991).
Research suggests that this scale has excellent internal consistency, good test-retest
reliability, acceptable interrater reliability, and that validity is generally supported
(DuPaul).
Several rating scales also are available for evaluating conduct, oppositional,
and aggressive problems (O’Leary & Johnson, 1986). Research from drug studies
indicates that the TRS (Conners, 1990) and Conners Parent Rating Scale (CPRS;
Conners, 1970) are the most sensitive to treatment effects (Aman, 1993). The TRS is
a 39-item instrument with four subscales (a) Conduct Problem, (b) Inattention, (c)
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Tension/Anxiety, and (d) Hyperactivity. An abbreviated version of this scale, the
Abbreviated Symptom Questionnaire, may be used when assessing drug effects
(Cormors, 1990).
There are two versions of the CPRS, a long version and a short version. The
long version is a 93-item instrument with eight subscales (a) Conduct Disorder, (b)
Anxious-Shy, (c) Restless/Disorganized, (d) Learning Problem, (e) Psychosomatic,
(f) Obsessive Compulsive, (g) Antisocial, and (h) Hyperactive-Immature. The short
version is a 48-item instrument with five subscales (a) Conduct Problem, (b) Learning
Problem, (c) Psychosomatic, (d) Impulsive-Hyperactive, and (e) Anxiety. Of the two
versions, the longer version has been shown to be more sensitive to drug effects
(Conners, 1970).
Rating scales assessing depression and anxiety are available, but have not
been shown to be sufficiently sensitive to drug effects. That is, while there are a
multitude of instruments for assessing childhood depression and anxiety, there have
been few well-controlled psychotropic drug trials conducted with anxiety disorders
and depression in children and adolescents (Aman, 1993; Brown & Sawyer, 1998).
Thus the validity of depression rating scales and anxiety rating scales in assessment
of drug efficacy is uncertain. Additionally, the value of depression rating scales in
drug trials is complicated by the fact that changes in depression ratings may occur
independent of treatment efficacy because ratings tend to improve with repeated
administrations (Brown & Sawyer). With regard to anxiety scales, Klein (1988)
recommended that any assessment of drug effects include an evaluation of both state
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and trait anxiety. State anxiety is described as being a relatively transitory
characteristic of a child’s personality and in response to a given stressor. Trait
anxiety, in contrast, is presumed to reflect a stable characteristic of a child’s
personality (Aman).
Direct observations of behavior also can be used to monitor the effects of
psychotropic medication, and studies show that such measures can be sensitive, valid,
and reliable (Gadow & Poling, 1988). A problem, however, is that such measures are
too resource-intensive to be used in the practical everyday evaluation of psychotropic
medications.

Systematic Assessment of Adverse (Side) Effects

Adequate monitoring of the physical side effects of psychotropic medication
is imperative. As noted previously, children frequently do not complain overtly about
physical problems and, at times, find it difficult to describe physical symptoms
(Brown & Sawyer, 1998). Additionally, children and adolescents develop rapidly.
Particular attention needs to be directed toward drug effects on physical development,
especially where a medication is given for long periods (Zametkin & Yamada, 1993).
Ideally, prior to the initiation of medication, an initial baseline should be
obtained to index behavioral and physical status prior to medication therapy
(Kalachnik et al., 1998; Zametkin & Yamada, 1993). Then, occasional monitoring of
relevant signs and symptoms can detect possible drug-induced side effects.
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There are several approaches available for systematic assessment of adverse
medication effects. These include rating scales, checklists, physical and neurological
examinations, and electrophysiological studies (Brown & Sawyer, 1998; Kalachnik et
al., 1998; Zametkin & Yamada, 1993). The use of a rating scale, though not common,
is encouraged since it may detect medication-induced symptoms that the patient or
family might not otherwise notice (Brown & Sawyer; Zametkin & Yamada). That is,
these measures may call attention to signs and symptoms that a parent or child may
not spontaneously report. Some possible rating scales include the Dosage Record and
Treatment Emergent Symptom Scale (DOTES; Guy, 1976a), the Subjective
Treatment Emergent Symptom Scale (STESS; Guy, 1976b), and the Abnormal
Involuntary Movement Scale (AIMS; Guy, 1976c).
The DOTES assesses many central nervous system (CNS) side effects as well
as some behavioral side effects. It involves a systematic review of all body systems
through both inquiry and simple physical exam (Guy, 1976a). It also requires
judgments on intensity, relationship of symptoms to the medication, and action taken
for each symptom occurrence. The STESS is a 32-item, five-point scale suitable for
children up to 15 years of age (Guy, 1976b; Zametkin & Yamada, 1993). This scale
may be completed by the child, parent, or other rater and was designed to acquire
information on the existence of physical complaints. The AIMS is the most widely
used standardized rating instrument in the assessment of tardive dyskinesia (Zametkin
& Yamada). It is a global 12-item, five-point severity scale consisting of dyskinetic
ratings of the face, lips, tongue, upper and lower extremities, and trunk (Guy, 1976c).
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As mentioned previously, a baseline of symptomology should be attained before the
initiation of drug treatment. This could be accomplished by completing a rating scale
prior to medication treatment.
Researchers also recommend that physical and neurological examinations be a
routine part of monitoring for adverse side effects in children and adolescents.
However, numerous methodological difficulties and psychometric problems
characterize neurological assessments, and future research efforts need to focus on
developing a standardized neurological examination to quantify many of the adverse
neurological effects associated with some psychotropic medications (Brown &
Sawyer, 1998). Additionally, it is recommended that assessment of the heart’s
electrical

condition

via

electrocardiogram

(EKG)

and

a

complete

electroencephalography (EEG) be conducted when certain drugs are prescribed. Most
psychotropic drugs, however, do not produce cardiac toxicity.

Research on School-Aged Children and Systematic Monitoring of Medication

Almost nothing is known concerning how the effects of psychotropic
medications typically are monitored in students with ED (Singh, Epstein, Leubke, &
Singh, 1990). There is, however, a sizable literature concerning students with a
diagnosis of ADHD. With the rise in the use of methylphenidate in the early 1970s
for the treatment of ADHD, much attention was given to the fact that the monitoring
of drug effects was less than adequate (Bosco & Robin, 1976; Loney & Ordona,
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1975; Robin & Bosco, 1973; Sandoval, Lambert, & Yandell, 1976; Solomons, 1973;
Weithom & Ross, 1975).
Researchers found that diagnostic practices were idiosyncratic and rarely
based on operational definitions of symptoms or normative data. Dosage adjustments
were indiscriminate. There was no direct contact between the physicians and
classroom teachers, and systematic instruments for evaluating drug effects were
rarely used. Anecdotal reports from parents were the standard means for obtaining
information about drug effects. Furthermore, many parents adjusted dosage on their
own.
Recent research has shown that the passage of time has not significantly
changed these conditions. Parents usually depend on their physician to diagnose
ADHD and prescribe a medication for it without fully understanding the
consequences of administering such medication (Brown & Sawyer, 1998; Gadow,
1982, 1983; Gadow, Nolan, Paolicelli, & Sprafkin, 1991; Werry, 1993). Gadow et al.
foimd that contacts between physicians and classroom teachers and the use of wellvalidated assessment instruments are rare. Teachers are often uninformed about the
medication being used and physicians generally have limited knowledge about a
child’s behavior at school. Furthermore, the decision to medicate and to continue
medication use typically is made by a pediatrician based on informal information
provided by parents.
Other research has suggested that children’s actual behavior may have little
influence on these decisions (Bruelle, Barton, & Foskett, 1983). In this study.
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physicians were surveyed to obtain perceptions of the information relayed between
them and parents and school personnel regarding the effects of medications used with
handicapped children. Results indicated that the physicians reported that little
information was actually exchanged. While the majority of physicians received some
information from school personnel prior to initiating therapy, only 33% considered
that information to be objective. Furthermore, 43% of the physicians indicated that
they provided information to the schools, and 62% said that they received some
information from the schools concerning the effectiveness of the medications, but
only 10% felt that this information was objective.

School Involvement in Systematic Monitoring of Psychotropic Medication

The high rate of pharmacological interventions for students vsdth ED should be
of interest to school personnel, as they are in a position to provide the prescribing
physicians with key information relevant to the effectiveness of the medications. The
school setting is in a sense a microcosm of society and represents a place where
students and adults work, play, eat and live together for six hours per day, five days
per week, at least 180 days per year. In fact, by the end of 5* grade, children will
have spent a minimum total of 5,400 hours in school (Gresham, 1997). In light of the
fact that children spend a significant portion of their lives in school, the involvement
of school personnel in monitoring drug effects appears to be essential to determine
the efficacy of prescribed medications (Brown et al., 1994). That is, school personnel
are in contact with children for prolonged periods within a structured setting and have
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opportunities to observe children in situations to which the parents may not have
access (Gadow & Nolan, 1993). Thus, input from school personnel is invaluable for
making decisions regarding the effects of medications (Brown et al.; Gadow, 1982,
1983; Weithom & Ross, 1975). Additionally, the school setting offers a unique
opportunity to evaluate the effectiveness of medications and to monitor changes over
time (Brown & Sawyer, 1998). For example, behaviors such as motor movement, offtask behavior, disturbing others, and noncompliance can be observed in students
performing academic tasks and interacting with peers in classroom settings, whereas
physical aggression and other inappropriate social behaviors can be observed on the
playgroxmd (Gadow & Nolan).
In view of the obvious potential importance of data collected at school in
determining the effectiveness of drug treatments for students with ED, it is interesting
that research examining teacher perceptions of medication usage with this population
suggests that teachers perceive school personnel as having little influence on the
decision-making process for prescribing or discontinuing medications for their
students (Singh et al., 1990). Singh et al. surveyed teachers to explore their
perceptions, knowledge, and opinions regarding medication used with their students.
Their results indicated teachers believed that the student’s doctor was the principal
decision-maker in having the student put on or taken off medication for behavior
disorders and that the parents, the school psychologist, and the student’s case
committee had some influence as well. Additionally, the results indicated that global
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impressions were perceived as the major index for drug evaluations, although, in an
ideal situation, informal teachers’ diaries would be the assessment method of choice.

Rationale for the Present Study

Because so little is known about the topic, although it is obviously important,
the present study examined how medication effects typically are monitored in
students with ED. The current project was intended to examine parent’s/teacher’s
knowledge regarding the reason for which psychotropic medication(s) are prescribed
to their children/students, the potential side effects for this medication(s), and the
desired effects of the medication(s). It also is intended to develop and evaluate a
monitoring system that is deemed useful by physicians and practical by parents and/or
school staff.

This strategy involved the use of two instruments, the Nisonger Child

Behavior Rating Form (CBRF) and the Detection of Side Effects Scale (DOSES).
The project was a sequel to a previous study, which examined if and how
parents and teachers of students with mental retardation, autism and/or other
developmental disabilities monitored the effects of psychotropic medication(s)
prescribed to their children or students (Turner, 2002). The study also developed and
evaluated what was hoped to be a practical and sustainable method for systematically
monitoring the effects of psychotropic drugs in school and home settings. Results
suggest that both parents and teachers knew relatively little about the behaviors the
medications were supposed to improve and that drug effects were almost never
systematically monitored at school or at home. Interestingly, a high percentage of
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parents/guardians indicated that they were satisfied with the current method of
evaluating their child’s medications, even though none of them employed a
systematic monitoring system.
When given the opportunity to use a monitoring system based on a modified
version of the Aberrant Behavior Checklist, an instrument developed to assess the
effects of psychotropic drugs in people with mental retardation (Aman, Singh,
Stewart, & Field, 1985), most parents and teachers indicated that the system was time
efficient and beneficial to the student. However, input fiom physicians was not
obtained in this study, which is a significant limitation. Unless psychiatrists and other
physicians who prescribe psychotropic medication find the results of a monitoring
system useful in making data-based treatment decisions, those results are of no
practical benefit to the children who receive medication.
The present project was initiated at the request of personnel from the Van
Buren Behavioral Education Center School (VBBECS), which primarily serves
students with El and serious behavioral problems.

School persormel related that

many of those students receive psychotropic medication, but their involvement in
assessing the effects of the medication was unsystematic, at best.
School persormel also indicated that a psychiatrist who prescribed
psychotropic medication for several students was interested in participating in a
project designed to improve monitoring of the effects of those drugs. Medication
monitoring affects the treatment of students only if physicians are actively involved;
therefore the psychiatrist's willingness to participate in the project was invaluable.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

METHODS

Participants and Setting

The target population for this study was school-aged children who had
received a special education label of El and were prescribed psychotropic
medication(s). These students attend the VBBECS and were identified by the School
Social Worker (SSW). Thirty-six students attended this school at the time of the study
and each of them qualified for special education services under the category of EL
Appendix A provides the definition of El currently used by the Michigan Department
ofEducation(R 340.1706).
Written notification was sent home with all of these students requesting
parent/guardian permission for the investigator to contact them (See Appendix B).
Interested parents/guardians returned the permission form to the School Social
Worker, who provided the investigator with the parent’s/guardian’s identifying
information. The investigator contacted these parents/guardians via phone and an
interview was conducted. Sixteen parents/guardians consented to an interview.
The parent/guardian interviews were conducted in a semi-structured format
and took approximately 15 minutes. Verbal consent was obtained at the onset of the
interview, a written copy of which was later mailed to the parent/guardian for a
signature (See Appendix C). Consent also was obtained for the investigator to contact
the student’s primary teacher and to contact the student’s prescribing physician.
24

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

25

signature (See Appendix C). Consent also was obtained for the investigator to contact
the student’s primary teacher and to contact the student’s prescribing physician.
Letters describing the study were then sent to the two main prescribing
physicians for the 16 students (See Appendix D). One physician, who prescribed
medication for five students, consented to an interview. This interview was held after
all of the written consents fi*om the parents/guardians were received. It was conducted
in the physician’s office in a semi-structured format and took approximately 70
minutes. The five students served by this physician participated in the study, in the
sense that information was obtained about them.

Each of the students was a

Caucasian boy. Students 1, 2, 3, 4, and 5 were 14-, 13-, 16-, 11-, and 16-years old,
respectively.

Procedure

Information was gathered from the parents/guardians and teachers of these
students regarding medication usage. Additionally, the Nisonger CBRF-Parent and
CBRF-Teacher scales were completed monthly by the student’s parent/guardian and
teacher. Of the parent/guardian informants, four were the biological mothers and one
was the grandmother of the students. Of the teacher informants, three indicated that
they had known the student they were evaluating for at least three months and one
indicated that she had known the student she was evaluating for less than three
months. Additional information was collected from the prescribing physician
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regarding the rationale for the medication prescription. The physician had known all
of the students more than 12 months.
After completion of the parent/guardian interview and the physician interview,
the student’s primary teacher was contacted via phone and an interview time was
arranged. Similar interviews were conducted with the primary teachers at the
VBBECS and took approximately 30 minutes. Consent for participation was received
at the onset of the interview (See Appendix E). Following the interview, and once a
month for the next two months, the teachers completed the Nisonger CBRF-Teacher
scale and the DOSES.
Following the interview and once a month for the next three months the
parents/guardians were mailed the Nisonger CBRF-Parent scale and the DOSES to be
completed. The forms were sent home with the student with a return envelope to be
returned to the SSW. If forms were not returned within a week, a second set of forms
was sent home with the student. All of the parents/guardians except for one
completed the scales every month. The parent/guardian who failed to return all of the
scales only returned scales for two of the four months.
When all of the initial Nisonger CBRF-Parent and -Teacher scales were
received, individual data collection forms for the student’s behaviors were developed
(See Appendices F, G, H, I, J, and K). These forms were used daily by the teachers to
monitor each student’s behavior at school. The lists of specific behaviors for which
data were collected were based on the initial scales completed by parents/guardians
and teachers and fi'om the information gleaned from the physician. If a behavior was
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rated as a “3” on either the parent or teacher scale and it was an observable and
measurable behavior, then it was monitored. Additional behaviors were added per the
physician’s request during the physician interview. Each data collection sheet was
developed with input from the teacher regarding the specific format. Thus each sheet
is different from each other, and the contents of individual’s sheets depended on
teacher preference regarding format and the number and kinds of behaviors that were
monitored.
Following two months of filling out both the Nisonger CBRF and DOSES
scales the teachers and parents/guardians completed an acceptability survey. This
survey was designed to provide the examiner with feedback evaluating the
practicality and acceptability of both scales.

Instruments

Parent/Guardian and Teacher Interview Forms

The instrument used in the semi-structured interview was comprised of two
sections (See Appendices L and M). The first section requested a) information about
the student’s prescribed medication, b) information regarding knowledge about the
intended

effects of the medication,

c)

information regarding medication

administration, d) information regarding psychiatric diagnosis, and e) information
about the degree of satisfaction with the results produced by the medication that the
student currently is receiving.
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The second section included questions ascertaining a) parent/guardian
knowledge about whether the medication was prescribed to treat behaviors in each of
the six categories summarized on the Nisonger CBRF, b) if these behaviors were
being monitored in any manner, c) the current status of those behaviors, and d)
satisfaction regarding the results produced by the medication on those behaviors. The
behavioral categories of interest were a) Conduct Problem, b) Insecure/Anxious, c)
Hyperactive, d) Self-Injury/Stereotypic, e) Self-Isolated/Ritualistic, and f) Irritable.

Phvsician Interview Form

The instrument used in the semi-structured interview included questions
ascertaining information regarding a) the student’s psychiatric diagnosis, b) the
student’s current medications, c) if and how information is received regarding the
severity of the psychiatric diagnosis, d) if any medications were prescribed to deal
with behaviors not indicative of a psychiatric condition, and e) if there is any
additional information the physician would like to receive relevant to the effects of
the psychotropic medication(s) prescribed for each student (See Appendix N).

The Nisonger Child Behavior Rating Form

The Nisonger CBRF is a 76-item rating form that was adapted from
Edelbrocks Child Behavior Rating Form (Edlebrock, 1985) (See Appendix O). The
Nisonger CBRF consists of two versions, parent and teacher, and contains two
sections. Social Competence and Problem Behaviors. The Social Competence section
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contains 10 items describing adaptive/prosocial types of behavior which are rated on
a 4-point Likert scale. The Problem Behavior section contains 66 items describing
externalizing and internalizing problem behaviors that are rated on a 4-point Likert
scale taking into account a combination of rate of occurrence and degree to which the
behavior presents a problem (Aman, Tasse, Rojahn, & Hammer, 1996; Tasse, Aman,
Hammer, & Rojahn, 1996).

Detection of Side Effects Scale

The DOSES is a 37-item rating form that lists behaviors and physiological
symptoms that are characteristic of side effects associated with psychotropic and
antiepileptic medication (See Appendix P). All of the items are rated on a 4-point
Likert scale indicating severity, i.e., “not at all”, “a little”, “pretty much”, and “very
much”. The rating additionally indicates if the item is “New” or if it is “More
Severe” relative to the previous rating (Kalachnik, 1988).

Acceptabilitv Survev Form

The instrument used for the acceptability survey included questions
ascertaining a) behaviors or physiological side effects listed that were unclear, b)
satisfaction with both scales, c) difficulty in understanding directions, and d)

feasibility of completing the survey on a monthly basis (See Appendices Q and R).
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RESULTS

Medication Report

The medications students were prescribed are displayed in Table 1. Students
received anywhere from two to four prescribed psychotropic medications. It should
be noted that over the comse of the study Student 3 underwent a medication changed.
The citalopram and the bupropion were discontinued and a new medication,
escitalopram oxalate (Lexipro), was started.

Side Effects

Data relevant to parent’s/guardian’s knowledge of side effects are displayed
in Table 2. One of the parents/guardians was familiar with the potential side effects of
at least one of the prescribed medications. Four of the parents/guardians were not
familiar with any of the potential side effects of the prescribed medications.

30
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Table 1
Student’s Prescribed Medications

Student

Med I

Med II

1

risperidone
(Risperdal)

gabapentin
(Neurotin)

2

sertraline
(Zoloft)

olazapine
(Zyprexa)

3

citalopram
(Celexa)

bupropion
(Wellbutrin)

4

valproic acid
(Depakote)

catapres
(Clonidine)

5

sertraline
(Zoloft)

nefazodone
(Serzone)

Med m

Med IV

valproic acid
(Depakote)

buspiron
(Buspar)

methylphenidate
(Concerta)

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

32
Table 2
Parent/Guardian Knowledge of Psychotropic
Medication Potential Side Effects

Studei

No. of prescribed
medications

No. of medications with
known side effects

1

2

0

2

4

0

3

2

1

4

3

0

5

2

0

Medication Administration

Four of the five parents/guardians reported that medication administration was
not a concern. All of them reported that an adult administered the medication and two
reported using a weekly pill container that was given to them by the prescribing
physician. One parent/guardian reported that her child’s medications were
administered at school and that sometimes on the weekend her child does not take any
medication.
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Psychiatric Diagnosis

The parent’s/guardian’s reports of psychiatric diagnoses are displayed in
Table 3 and the psychiatric diagnoses provided by the physician are displayed in
Table 4. The results displayed in these two tables indicate that parent’s/guardian’s
impression of their child’s diagnosis differed significantly from the actual psychiatric
diagnosis provided by the physician.

Table 3
Parent’s/Guardian’s Reports of Psychiatric Diagnosis

Student

Diagnosis I

Diagnosis II

Student 1

Oppositional Defiant Disorder

Bipolar

Student 2

Bi polar

Student 3

Emotional Impairment

Compulsive
Disorder

Student 4

Attention Deficit Hyperactivity
Disorder

Impulsive
Disorder

Student 5

Attention Deficit Hj^eractivity
Disorder

Diagnosis III

Bipolar Manic
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Table 4
Physician’s Description of Student’s Psychiatric Diagnoses

Student

Diagnosis I

Diagnosis II

Student 1

Bi polar with psychotic features

Student 2

Depression with psychotic features

Student 3

Depression

Student 4

Attention Deficit Hyperactivity Disorder

Student 5

None

Bi polar

Seizure Disorder

Satisfaction

Overall, four of the five parents/guardians were “somewhat satisfied” with the
results produced by the medication. One parent/guardian was “very satisfied” with the
results.

Behavioral Category Knowledge

Findings relevant to parent/guardian knowledge about the behavioral
categories for which their child’s medications were prescribed are displayed in Table
5. The results indicate that medication was most often prescribed for conduct
problems. Three of the parents/guardians indicated that a medication was prescribed
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for this category. One parent/guardian indicated that a medication was prescribed for
hyperactive behaviors and one parent/guardian indicated that a medication was
prescribed for self-injury/stereotypic behaviors. Parent/guardian responses indicate
that in most cases either a medication was not prescribed to deal with a behavioral
category or it was unknown if a medication was prescribed to deal with a behavioral
category.

Table 5
Parent/Guardian Knowledge of Behavioral Categories for
Which the Medication was Prescribed

Behavioral Category

Yes

No

Don’t Know

Conduct Problems

3

1

1

Insecure/Anxious

0

2

3

Hyperactive

1

2

2

Self-Injury/
Stereotypic

1

2

2

Self-Isolated/
Ritualistic

0

3

2

Irritable

0

3

2

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

36

The Nisonger CBRF-Parent, -Teacher Scales

Based on the results of interviews with parents/guardians and the physician,
the primary Nisonger CBRF problem behavior categories for which students were
prescribed medication were determined. Table 6 lists those categories.

Table 6
Nisonger-CBRF Problem Behavior Category or Categories
for Which Medication was Prescribed

Student

Nisonger CBRF Category or Categories

1

Conduct Problems

2

Inseciue/Anxious, Self-Injury/Stereotypic

3

Insecure/Anxious

4

Conduct Problems, Hyperactive

5

Conduct Problems, Self-Injury/Stereotypic

Parent/guardian- and teacher-reported evaluations o f students using the

Nisonger CBRF-Parent and -Teacher scales, respectively, are presented in Tables 716. Tables 17 and 18 provide normative data for these instruments.
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Nisonger CBRF - Parent Version: Totals for Subject 5
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Problem
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Self-Injury/
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Sensitive

6
6
6
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4
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Nisonger CBRF -- Teacher Version: Totals for Subject 1
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Nisonger CBRF - Teacher Version ; Totals for Subject 2
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Nisonger CBRF - Teacher Version for Subject 4
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Table 17
Norm Data for the Nisonger CBRF-Parent Version, Means, and Standard Deviation
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Compliant/
Adaptive
Conduct
Insecure/
Calm________Social______ Problem______Anxious
M
SD
M
SD
M
SD
M
SD

Age (Years)

n

7-9
10-16

65 7,25
68 6.72

Hyperactive
M
SD

Self-Injury/
Stereotypic
M
SD

13.20 7.91
15.00 7.38

2.63
3.38

Isolated/
Ritualistic
M
SD

Overly
Sensitive
M
SD

c
CD

■CDD

3.63
3.50

4.63
4.49

2.88
2.47

18.06
19.93

13.48 7.66
14.03 10.88

7.89
9.65

4.19
4.62

5.00
6.66

4.51
5.58

5.82
5.87

3.94
3.81
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n = number of participants; M = mean; SD = standard deviation
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Table 18
Norm Data for the Nisonger CBRF-Teacher Version, Means, and Standard Deviation
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Age (Years)

n

Compliant/
Adaptive
Conduct
Insecure/
Calm_______ Social_______Problem______ Anxious
M
SD
M
SD
M
SD
M
SD

7-9
10-16

61
67

6.25
5.96

Hyperactive
M
SD

Self-Injury/
Stereotypic
M
SD

SelfIsolated/
Ritualistic
M
SD

Overly
Sensitive
M
SD

4.30
5.10

7.72
9.06

6.79
7.25
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3.70
3.78

5.51
5.36

3.35
3.44

12.60 10.20 7.16 6.84
13.20 11.00 10.70 10.40
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n = number of participants; M = mean; SD = standard deviation

12.50 6.40
11.10 6.60

5.71
5.73

6.86
6.95

5.48
5.37
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In all cases, scores for all behavioral categories for each participant were within one
standard deviation of the norm mean. This finding suggests that, although variability
was evident across and within students, behavior in the rated categories did not differ
markedly from that of the norm group at any time in the study. Moreover, it suggests
that ratings by parents/guardians and teachers were similar. To quantify inter-rater
agreement, a Pearson product-moment correlation was calculated between the
monthly scores reported by parents/guardians and teachers. The resultant value was r
= 0.49, p < .001.
In most cases, the ratings were relatively consistent across moiiths. In a few
cases, there were substantial changes in the ratings on particular categories across
time. When this happened, the score usually changed substantially from one rating to
the next, then remained fairly constant. Such a pattern is evident for Subject 1 on the
parent/guardian category scores for Conduct Problem. The first score for this category
was significantly higher than the following months scores. These scores decreased
from the first month and then remained fairly constant. Likewise, for Subject 1 on the
teacher category scores for Conduct Problem and Insecure/Anxious, the first score for
both of these categories was signifieantly higher than the following months’ scores,
which were similar.

Detection o f Side Effects Scale

The DOSES items rated as new/more severe may be clues of emerging side
effects. The same is true of items rated as two or three, unless these ratings can be
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attributed with confidence to causes other than psychotropic medication (e.g.
seizures/convulsions, item 16, might occur due to uncontrollable epilepsy). Tables 19
- 23 list for each student items listed as new/more severe and those scored as two or
three.

Acceptability Survey

The results of this survey indicate that both the Nisonger CBRF and DOSES
scales were easy to understand and were rated as satisfactory instruments for
assessing troublesome behavior and medication side effects in children with El (See
Appendices S and T).
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Table 19
Student 1 - Summary of Parent DOSES

Month

Item

Score

New/More Severe

Trouble concentrating
3
More Severe
Rash
New
3
Tired
3
New
Sleeping —less
2
New
Urination - more
1
New
Speech - Mumbling
3
No
February
Trouble getting along with staff
No
3
Irritable
3
No
Sad
3
No
Trouble seeing
2
No
Withdrawn/Talks less
2
No
Trouble performing usual activities or playing sports
2
No
Comments - Subject 1 has complained that he can’t sleep at night. On the other hand he has been known to
take street drugs. He seems very sleepy, unmotivated, sad, moody and the next day be happy and laughing all
day.
Excessive Energy
2
No
Irritable
2
No
March
Sleeping - trouble getting to sleep
2
No
Trouble concentrating
2
No
Unusual skin temperature
2
No
April
Sleeping
2
No
Comments - Subject 1 has been doing better, trying harder and working harder.
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Table 20
Student 2 - Summary of Parent DOSES

Month

Item

Score

New/More Severe

2
New
Urination - delayed
2
Irritable
No
February
Trouble getting along with other clients
2
No
2
Crying
No
Comments - Subject 1 has been complaining that he has been having trouble urinating. He has had a severe
cold and has been on a strong antibiotic. He has been improving over the past year except when someone
blames him for something he did not do. He gets very defensive. 1 am very happy with Dr. Bui and the way
she takes care o f him.
Sleeping - more
3
New
New
Stuffy Nose/Runny N ose/ Congestion
3
3
New
Irritable/Gets Angry Easily
New
Sad/Not Happy/Seems More Serious
3
1
Headache
New
1
New
Trouble Getting Along with Other Clients
March
1
Urination - painful
New
Bowel Movements —more diarrhea
1
New
Trouble Getting Along with StafEHard to Please
3
No
Crying
3
No
Tired/Feeling Sleepy/Decreased Energy
3
No
2
Trouble Concentrating/Difficulty Paying Attention
No
Eating - more
No
2
Comments - Can’t seem to control his temper when people push him to his limits. He is great arormd
family, but when he gets around new people or kids his own age or a lot o f people (as a group) he regresses.
If someone says the wrong thing or “gets setup” he does not know how to handle it.
2
Itchy/Scratchy Skin - head
New
Saliva
1
New
3
No
Ciying
Sleeping - more
3
No
Irritable/Gets Angry Easily
3
No
April
Trouble Getting Along with StafEHard to Please
3
No
Trouble Getting Along with Other Clients
3
No
2
Tired/Feeling Sleepy/Decreased Energy
No
Trouble Concentrating/Difficulty Paying Attention
2
No
Sad/Not Happy/Seems More Serious
2
No
Eating - more
2
No
Comments - Can’t seem to control his temper when told what to do and when is pushed to his limits. Seems
to be having a problem getting along with adults at school and kids on the bus at this time. He is good at
home but does not like to be told what to do by anyone besides me for some reason. When he gets in trouble
at home and 1 correct him he is very sony for what he does (right away).
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Table 20 - Continued

Month

Item

Score

New/More Severe

Itchy/Scratchy Skin
3
More Severe
Crying
3
No
3
No
Sleeping - more
May
Irritable/Gets Angty Easily
2
No
Sad/Not Happy/Seems More Serious
No
2
Trouble Getting Along with Other Clients
2
No
Comments - Seems to have outbursts o f anger more frequently since school had been out. It doesn’t take
him long to get over it, and is always sorry that he lost it, but in the mean time he says some really bad things.

Table 21
Student 3 - Summaiy of Parent DOSES

Month

February

Item

Score

New/More Severe

Drinking
Trouble Performing usual Activities or Playing Sports
Sweating
hritable/Gets Angry Easily
Eating
Tired/Feeling Sleepy/Decreased Energy
Headache
Sad/Not Happy/Seems More Serious
Withdrawn/Talks Less
Sick to Stomach
Sleeping
Stomach: Aches/Discomfort/Heartbum
Trouble Getting Along with StafPHard to Please

2
2
3
3
3
3
2
2
2
I
1
1
1

No
No
More Severe
More Severe
New
New
New
New
New
New
New
New
New
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Table 21 - Continued

Month

Item

Score

New/More Severe

Eating
3
More Severe
Headache
3
More Severe
3
More Severe
Irritable/Gets Angry Easily
Sad/Not Happy/Seems More Serious
More Severe
3
Tired/Feeling Sleepy/Decreased Energy
More Severe
3
Withdrawn/Talks Less
More Severe
3
Trouble Concentrating
More Severe
2
Trouble Doing Things with Hands/Less Steady Using Hands
2
More Severe
April
Muscles - pain and stiff
1
New
Drinking - more
1
New
Unusual Skin Temperature - cold sweats
1
New
Sweating
1
New
Sleeping - more
3
No
Bowel Movements
2
No
Clumsy/Poor Balance/Stumbling
2
No
Trouble Getting Along with Other Clients
2
No
Comments - He has had very low motivation doing things arormd house or caring for self. Very
argumentative when trying to keep him on task, compulsive lying or excuses why he is not doing things
expected. Seem sveiy hateful.
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Table 22
Student 4 - Summary of Parent DOSES

Month

Item

Score

New/More Severe

Excessive Energy/Constantly On The Go
2
More Severe
Headache
2
More Severe
2
Irritable/Gets Angry Easily
More Severe
Bowel Movements - less
2
New
1
Crying
More Severe
Urination - more
1
New
1
Withdrawn/Talks Less
New
Dizziness
1
New
Drinking - more
1
New
1
Eating - more
New
February
Itchy /Scratchy Skin
1
New
Muscle - pain
1
New
Sad/Not Happy/Seems More Serious
1
New
Sleeping - more
1
New
1
Trouble Doing Things with Hands/Less Steady Using Hands
New
Saliva - less
2
No
Shakiness/Tremor - hands
2
No
Sweating - more
2
No
Trouble Concentrating/Difficulty Paying Attention
2
No
Trouble Sitting Still/Jittery
2
No
Comments - He has had a couple o f incidents o f bedwetting, but is not a constant problem. His
stomachaches are usually due to his taking his medication but not taking time to eat.
Sleeping - Trouble Getting to Sleep
3
More Severe
Shakiness/Tremor - hands
2
More Severe
2
Trouble Doing Things with Hands/Less Steady Using Hands
More Severe
Stomach: Aches/Discomfort/Heartburn
2
More Severe
Urination - bedwetting
1
New
Trouble Seeing - blurred
1
New
March
Saliva - more
1
New
Irritable/Gets An^y Easily
3
No
Excessive Energy/Constantly On The Go
2
No
Bowel Movements - less
2
No
Trouble Concentrating/DifKculty Paying Attention
2
No
Trouble Getting Along with StafEHard to Please
2
No
Trouble Sitting
2
No
Comments - He seems more difficult to control. He is also more impulsive; (example, on Tuesday April 8“*,
he got off the bus at a peer’s house). He is also more destructive, more moods and at times mean and
imcooperative in every aspect.
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Table 22 - Continued

Month

Item

Score

New/More Severe

Bowel Movements - more
1
New
2
No
Excessive energy/Constantly On The Go
April
Irritable/Gets Angry Easily
2
No
2
Trouble Sitting Still/Jittery
No
Comments - He tells me “No” more often. Has more o f an “I don’t care” attitude and expresses it freely. He
does as he wants and don’t care about the consequences until confronted with such consequences and then
blames the adult that’s canying out the punishment.
Bowel Movements - more
3
More Severe
Stomach: Aches/Discomfort
3
More Severe
2
Trouble Getting Along with StafGHard to Please
More Severe
2
Trouble Getting Along with Other Clients
More Severe
May
2
Irritable/Gets Angry Easily
More Severe
2
More Severe
Trouble Sitting Still/Jittery
Urination - painful
3
New
Muscles - cramps, stiff
3
New
Eating - more
2
No
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Table 23
Student 5 - Summary of Parent DOSES

Month

February

March

April

Item

Score

New/More Severe

Itchy/Scratchy Skin
Sleeping - less
Trouble Performing Usual Activities or Playing Sports
Stuffy Nose/Runny Nose/Congestion
Headache
Excessive Energy/Constantly on the Go
Sleeping - Staying Asleep
Trouble Getting Along with StafBHard to Please
Trouble Getting Along with Other Clients
Tired/Feeling Sleepy/Decreased Energy
S tu ^ Nose/Rimny Nose/Congestion
Simbums Easily
Trouble Performing Usual Activities or Playing Sports

2
2
2
2
1
1
1
1
1
1
2
2
2

More Severe
More Severe
More Severe
More Severe
More Severe
More Severe
More Severe
More Severe
More Severe
New
No
No
No
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DISCUSSION

Discussion

Research has shown that schools do not typically participate in the systematic
monitoring of psychotropic medications prescribed to school-aged children with
emotional disorders. Conversely, research indicates that the information that is
relayed to the prescribing physician from the schools consists, in general, of informal
global reports regarding the student's overall behavior. Additionally, research
evaluating systematic monitoring systems within schools has lacked input from the
prescribing physician regarding relevant data to be collected. These findings provided
impetus for the present project, which was an attempt to develop a practical system to
monitor possible desired and adverse effects of psychotropic medications.
For this project, input from parents/guardians, teachers, and an interested
psychiatrist was used to select procedures for measuring these effects. Possible
desired effects in several behavioral domains were assessed using the Nisonger
CBRF-Parent and -Teacher scales, whereas side effects were evaluated using the
DOSES. Data intended to reflect the status of students at home and at school were
obtained once a month from parents/gxiardians and teachers, respectively.
Parents/guardians and teachers were surveyed concerning their satisfaction with the
monitoring system and the results obtained were conveyed to the participating

53
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psychiatrist. Finally, information was obtained regarding the medication monitoring
process prior to the onset of the present.
Data relevant to the status of five students with an educational diagnosis of El
Were obtained. According to parents/guardians, each of the five students had received
a psychiatric diagnosis. According to the prescribing psychiatrist, four of the students
had

received

a

psychiatric

diagnosis.

The

diagnoses

described

by

the

parents/guardians and the psychiatrist agreed in only one of five cases, which is
interesting and distressing. It was not clear whether the discrepancies resulted from a
lack

of

communication

between

parents/guardians

and

the

physician,

misunderstanding or forgetting on the part of parents/guardians, or some other reason.
Each of the students received at least two psychotropic medications.
Regardless of whether the psychiatric diagnoses provided by the psychiatrist or the
parent/guardian are accepted, none of the drug combinations are known to be
effective, although some of the individual medications are known to be generally
effective for the indicated condition. For instance, methylphenidate is appropriate for
ADHD (Brown and Sawyer, 1998) and was prescribed for Student 4, diagnosed with
ADHD. With respect to the general kinds of problem behaviors for which drugs were
prescribed, "conduct problems" as defined by the Nisonger CBRF scales were
targeted for change in three students; hyperactivity and self-injuiy/stereotypy were
targeted in two.
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Given that research findings provided no basis for the use of the drug
combinations received by these students, the need for careful drug monitoring is
obvious. Nonetheless, no systematic monitoring was taking place prior to the current
study. During the present study, Nisonger CBRF ratings by parents/guardians and
teachers in each of the six behavioral categories were relatively consistent across time
and were within one standard deviation of the norm mean. This indicates that the
student’s behavior was not a cause for significant concern. How, or if, medication
affected their behavior was not determined in the present study, because no drugabsent data were collected. Given that this is the case, the present findings provide
only weak support for the continued use of medication, and a "drug holiday" should
be arranged to evaluate effectiveness. Had there been significant problems in
behavior domains that medications had been prescribed to treat, however, there would
have been justification for ending or adjusting drug treatment. Here, the medications
clearly are not doing what they are intended to do, and treatment should be changed.
Collecting data only in the presence of drugs can provide fairly strong evidence of the
absence of effectiveness, but not of its presence. Nonetheless, four of five
parent/guardians were "somewhat satisfied" with the results of medication, and one
was "very satisfied."
Although ratings typically were relatively consistent across time, there were a
few cases in which a category rating substantially changed. However, these changes
usually occurred from the first to the second completion of the scale. This pattern is
characterized as regression to the mean (Aman, 1993) and is a documented limitation
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of rating scales. To minimize this phenomenon it is suggested that children be
assessed at least twice during baseline, before instituting any form of therapy (Aman).
The comparisons would be between the second rating and subsequent ratings
obtained. Thus the first scale completed, which in all probability will have higher
category scores, is not regarded as the baseline score.
Although there was a statistically significant correlation between the ratings of
parents/guardians and those of teachers, its value was not especially high (r = .49).
That this is so is no reason for particular concern, given that home and school
environments differ in ways that are likely to foster different behaviors. It is,
however, possible that parents/guardians and teachers also rated similar behaviors
somewhat differently, and this possibility should be explored in future studies.
The results of the parent/guardian and teacher acceptability surveys indicate
that both the Nisonger CBRF scales and the DOSES were easy to understand.
Moreover, they were considered to be satisfactory instruments for assessing
troublesome behavior and medication side effects in children with emotional
impairments.
Results of the present study suggest that the parents/guardians and teachers of
students with El had a general lack of knowledge regarding the possible side effects
of the medications prescribed. Only one parent/guardian was familiar with some of
the side effects for one of the two medications prescribed. These results are similar to
those of previous studies involving parents/guardians and teachers of students with
developmental disabilities (Christian, Snycerski, Singh, & Poling, 1999; Turner,
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2002). Parents/guardians in these studies, as in the present one, had little knowledge
of possible adverse effects of the psychotropic medications that students received.
Research involving students with ADHD indicates that parents depend on their
physicians to prescribe a medication without understanding the possible adverse
consequences of administering such medications (Brown & Sawyer, 1998; Gadow,
1982, 1983; Gadow et al., 1991; Werry, 1993), and the present finding suggests that
this also is the case with respect to parents of students with EL
On the positive side, the present results suggest that medication
noncompliance was not a major problem with four of the five students. Medication
noncompliance is a significant issue in pediatric noncompliance (e.g., Baldessarini,
1996; Brown & Sawyer, 1998). Therefore, it is heartening that all of the
parents/guardians reported that an adult supervised the medication administration and
that four of the five parents/guardians reported that the medications were
administered per the physician’s orders. One parent/guardian reported that sometimes
on the weekend her child did not take any medication. The investigator suggested that
she should consult with the prescribing psychiatrist regarding this practice, and it
appears that she did so although it is not clear if the practice changed.
As noted previously, results of the teacher knowledge survey suggest that
teachers lacked knowledge regarding the side effeets of the prescribed medieations.
Interestingly, and unfortunately, they also lacked knowledge regarding student’s
psychiatric diagnosis and the reasons for which the students were prescribed
medications. None of the teachers was familiar with any of the prescribed

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

58
medications and none of them were aware of the student’s psychiatric diagnosis.
Additionally, none of the teachers was aware of the reasons for which the students
were prescribed medications. Teachers informally reported to the investigator that the
SSW was “in charge” of the medications. That is, the SSW was the individual who
was responsible for knowing about the medications prescribed, and for acting as a
liaison between the school and the psychiatrist. It appeared as though the teachers did
not view themselves as having an important role to play in ensuring that medications
were used appropriately with their students, although they were quite willing to be
involved in collecting data. Previous research indicates that teachers of students with
El view themselves as having little influence on issues pertaining to students’
medications (Singh et al., 1990), and the present findings support this conclusion.
Parents/guardians and teachers reported that the DOSES was relatively easy to
complete, and the DOSES data in some cases revealed changes in student’s physical
or behavioral status that may have been indicative of an emerging side effect. DOSES
data were shared with the prescribing physicians, but over the cowse of the study no
medication adjustments were made based on those data.
There were some general limitations of the current study. First, even though
the parent/guardian and teacher Nisonger CBRF scales were significantly correlated
with one another, it is not clear that either rating was accurate. For example, rater
subjectivity may have influenced what was deemed as a problem or not a problem.
Moreover, an inappropriate behavior displayed at school may have been construed as
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a problem; conversely the same behavior displayed at home may not have been seen
as a problem.
Second, while all Nisonger CBRF category scores for each student were close
to the standardized norm, as discussed previously, this does not necessarily mean that
the medication was effective. That is, a baseline prior to the medication
implementation was not attained, thus a comparison of behavior prior to drug therapy
was not possible. Moreover, a baseline of the physical and behavioral indices relevant
to side effects was not established prior to medication implementation, which
complicates the interpretation of obtained data.
Third, the students for which data were collected in this study constitute a
small and nonrandom sample of the population of students who have a special
education label of El and are currently receiving one or more psychotropic
medications. Therefore, the generality of the present results is limited.
Nonetheless, those results do suggest that monthly administration of Nisonger
CBRF scales combined with the DOSES may provide a rough-and-ready strategy for
indexing the effects of psychotropic medication in students with an EL
Parents/guardians, teachers, and the prescribing psychiatrist generally found this
system to be manageable and useful, and the results provide some evidence that the
medications were producing benefits without producing serious side effects.
A final limitation is that the participants selected for this study are a small and
nonrandom sample of the population of parents/guardians whose school-aged children
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have a special education label of El and currently receiving one or more psychotropic
medications. Thus, a generality of the present results is limited.
Although all relevant parties reported that the monitoring system was easy to
use, the investigator's role in the project was such that she performed some of the timeconsuming and potentially difficult tasks. For example, while the data entry process
was not difficult, it did require considerable time on the part of the investigator.
Another example of time consumption was the distribution of the scales. Again, this
was not a difficult task, but its completion did require some time. In addition, the
investigator sometimes had to send copies of the scales home with the student multiple
times to receive the parent/guardian monthly response. She also made phone calls to
parents/guardians reminding them to complete and return the monthly scales sent to
them. School personnel have many daily responsibilities that are mandated and time is
at a premium. Although the monitoring system examined in the present study was
designed to be quick and easy to use, it is not foregone that school persotmel alone
would have the time to implement the system.
In addition, some training is required to familiarize School personnel with the
system and to provide the expertise necessary to interpret results. That is, the
individual who will interpret the results to the family and to the prescribing physician
must be trained. Her or his task is not simply reporting category numbers. There must
be fundamental imderstanding of the purpose of the rating scale and of how results
should be interpreted, and most school personnel will have to be trained to develop the
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required expertise. Such training requires both time and money, which may be in short
supply in some school systems.
Power, Atkins, Osborne, and Blum (1994) suggest that school psychologists
may have an especially important role to play in developing and implementing
medication-monitoring systems in schools. School psychologists specialize in
evaluating child behavior and collaborating with others to bring about positive
changes in behavior. Consequently, Power et al. maintain that school psychologists
may be the best candidates for sharing data with physicians, thereby reducing the
likelihood of haphazard, or nonexistent, assessment.
Prior to the present study's implementation, the SSW was the individual
responsible for relaying all information to the prescribing physician. The SSW would
accompany parents/guardians and students on appointments with the psychiatrist and
discuss the student’s behavior. The SSW’s procedure for attaining relevant
information involved asking the teachers to write a brief summary of the student’s
behavior during the past several months. That is, the information relayed by the SSW
reflected the teacher’s global impressions of the student’s general status in the school
setting. At the end of the present study, the SSW was familiar with the Nisonger
CBRF scales and the DOSES, and was ready to report these data to the prescribing
psychiatrist. Although this system of medication monitoring is by no means ideal, and
falls well short of the elaborate systems proposed to evaluate the effects of stimulant
medications in students with ADHD (e.g., Gadow, Pomoroy, & Nolan, 1993; Hale,
Hoeppner, DeWitt, Corny, Ritacco, & Trommer, 1998). These systems, which make
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use of double-blind conditions and placebo controls, use cognitive performance tasks
and direct observation measures as primary indicators of drug effects.
While such models have much to recommend them from an assessment
perspective, practical limitations prevent their being used in most school systems
(Hyman et al., 1998; Swanson, Wigal, & Greenhill, 1998). A key issue in evaluating
the effects of psychotropic medications in school settings is developing procedures
that yield clinically meaningful data without unduly burdening school persormel. The
monitoring system used in the present study was intended to be a step in that
direction.

Future Directions

Because of the high number of psychotropic medications prescribed to schoolaged children with El, systematic monitoring of the effects of these medications could
be very valuable. In this regard, teachers need to be better informed of who in their
class is taking medications. Currently, parents are not required to inform the school
personnel if their child is prescribed a medication. This information is only required if
a dosage administration is necessary during the school day. Also, parents are not
required to inform school staff if there is a decrease or increase in medication dosage.
Again, this information is only required if it pertains to the dosage administered at the
school.
Second, school personnel (e.g., teachers, school psychologists, social workers)
need to be provided with general information regarding the effects of commonly
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prescribed medications. For example, a handout could be distributed to school
personnel as a reference guide. Thus the information would always be accessible to
them. This general information should include the rationale for using particular drugs,
their effects on academic and social behavior, and their common side effects.
Third, school personnel should be trained on how to monitor the behaviors that
medications are prescribed to target. Monitoring should occur before, during, and after
the use of drug therapies. For example, teachers will often inform parents when a
student is having difficulty and suggest that the student be taken to the doctor for an
evaluation. If teachers were familiar with simple monitoring procedures, data could be
collected regarding the behaviors in question. This information could then be relayed
to the physician as evidence of the student’s behavior.
Finally, school personnel should take the initiative in establishing policies for
ensuring that the data they collect are communicated to parents and physicians.
Monitoring of the effects of all psychotropic medication is likely to be needed if
substantial progress is to occur in the pharmacological treatment of students with El.
It would seem that if school personnel and physicians were required by law to
systematically monitor the effects of psychotropic medications prescribed for schoolaged children, this would be a major step in the right direction.
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Definition of Emotional Impairment
The Michigan Department of Education (R 340.1706) defines Emotional
Impairment as follows:
(1)

Emotional impairment shall be determined through manifestation of
behavioral problems primarily in the affective domain, over an extended
period of time, which adversely affect the student’s education to the extent
that the student cannot profit from learning experiences without special
education support. The problems result in behaviors manifested by 1 or more
of the following characteristics:
(a) Inability to build or maintain satisfactory interpersonal
relationships within the school environment.
(b) Inappropriate types of behavior or feelings under normal
circumstances.
(c) General pervasive mood of unhappiness or depression.
(d) Tendency to develop physical symptoms or fears associated with
personal or school problems.

(2)

Emotional impairment also includes students who, in addition to the
characteristics specified in subrule (1) of this rule, exhibit maladaptive
behaviors related to schizophrenia or similar disorders. The term “emotional
impairment” does not include persons who are socially maladjusted, unless it
is determined that the persons have an emotional impairment.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

79
(3)

Emotional impairment does not include students whose behaviors are
primarily the result of intellectual, sensory, or health factors.

(4)

When evaluating a student suspected of having an emotional impairment, the
multidisciplinary evaluation team report shall include documentation of all of
the following:
(a) The student’s performance in the educational setting and in other
settings, such as adaptive behavior within the broader community.
(b) The systematic observation of the behaviors of primary concern
which interfere with educational and social needs.
(c) The intervention strategies used to improve the behaviors and the
length of time the strategies were utilized.
(d) Relevant medical information, if any.

(5)

A determination of impairment shall be based on data provided by a
multidisciplinary evaluation team, which shall include a comprehensive
evaluation by both of the following:
(a) A psychologist or psychiatrist.
(b) A school social worker.
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Dear Parent,
We are working with faculty and students from W estern
Michigan University to improve procedures for determining the
e f f e c t s of medications prescribed to improve the behavior of
children with emotional impairments. The goal of the project is to
help school s t a f f to develop an e ffe c tiv e and practical medication
monitoring system that will provide information that parents and
physicians can use in determining whether th e medications are
working.
We are seeking approval for Lynne Turner, Graduate
Research Associate, to contact you by phone or in person, at your
choice, to provide further details. I f you would like to speak with
someone immediately, please call Lynne Turner at 2 6 9 -3 8 7 -4 4 7 8 , Al
Poling, Professor, at 2 6 9 -3 8 7 -4 4 8 3 or Kristal Ehrhardt, A ssociate
Professor, a t 269 -3 8 7 -4 4 7 8 .
Gene Vodgs
BEC Supervisor of Special Education
427-7961
Diane Mosley
BEC Social Worker
427-7921
□

Yes, I agree to be contacted.

□

No, I do not wish to be contacted.

Parent Signature
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W estern Michigan University

Department of Psychology
Principal Investigator: Alan Poling A Kristol Ehrhardt
Research Associate: Lynne Turner
Parent Permission
I have been invited to participate in a research project entitled "Monitoring the
E ffects of Psychotropic Drugs in Students with Emotional Impairments: Home and
School Data". The purpose of th e study is to evaluate how medication is monitored
in th e schools and a t home and to establish an ongoing monitoring system if one is
not currently in place. This project is being conducted to fulfill Lynne Turner's
dissertation requirements.
This project will be conducted in two phases. I agree in the firs t phase to be
interviewed to complete a brief questionnaire. The questionnaire includes questions
about my child's current medication and my satisfaction with this medication. The
interview will take no more than 20 minutes to complete. I also agree in the second
phase to monitor my child's behaviors.
My permission also means th a t my child's teacher may be contacted for an interview
to complete a similar questionnaire about my child's medication and behavior in the
classroom and th at my child's prescribing physician may be contacted about the
reason for my child's medication prescription. In addition, my permission serves as
a release allowing th e researchers to access confidential medical information from
the school social worker and my child's physician regarding my child.
The interview responses will be confidential. This means th at my child's name will
be omitted from all forms and a code number will be attached. The principal
investigator will keep a separate m aster list with th e names of th e children and the
corresponding code numbers. Once th e data are collected and analyzed, th e m aster
list will be destroyed. All other forms will be retained for th ree years in a locked
file in th e principal investigator's office. No names will be used if th e results are
published or reported a t a professional meeting.
I f I chose to participate, I may gain knowledge about the e ffects of th e medication
th at my child is taking. Additionally, I may find th a t my child's medication is being
used appropriately.
I f I choose to participate, I may find th at I am dissatisfied with th e medication my
child is prescribed. However, it is not th e researchers' purpose to bring about
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changes in medication, but to monitor the e ffe c ts of prescribed medication. I f I
am unhappy with my child's medication a t any time, I should consult with my child’s
physician to share my concerns before making any changes to my child’s treatm ent.
As in all research, there may be unforeseen risks to the participant. I f an
accidental injury occurs, appropriate emergency measures will be taken; however,
not compensation or additional treatm ent will be made available to th e subjects
except as otherwise stated in this consent.
I am free to term inate my involvement in the project a t any time during either
phase one or phase two. I f I choose to term inate my involvement, th ere will be no
negative consequences or penalties and my choice will not affect my child’s
enrollment in th e Van Buren School. I f I have any questions, I may contact Lynne
Turner a t 387-4498, Kristal Ehrhardt a t 387-4478 or Alan Poling 387-4483. I may
also contact th e chair of th e Human Subject Institutional Review Board a t 3878293 or the Vice President for Research a t 387-8298 with any concerns th a t I
have.
This permission document has been approved for use for one year by th e Human
Subjects Institutional Review Board as indicated by the stamped date and
signature of th e board chair in the upper right corner. Subjects should not sign
this document if th e corner does not have a stamped date and signature

Date

Time

You are making a decision whether or not to participate. Your signature indicates
th a t you have decided to participate having read th e information provided above.

Signature of Parent/Suardian

Signature of Investigator
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Dear Dr.________ ;
We invite you to participate in a project intended to determine how the effects of
psychotropic medications are monitored in students with emotional impairments and, if
necessary, to develop procedures for collecting information useful in making decisions about
the effectiveness of such medications. The project will involve examining for selected
students the cxurent system for collecting and reporting information, then if necessary to
modify or arrange procedures in light of input from prescribing physicians, parents/guardians,
and Van Buren Behavioral Education Center staff.
Your input will play a major role in determining the kind of data that are collected and how
these data are summarized and reported. We ask to meet briefly with you to determine; a)
the rationale for selected students’ current medication(s), b) the information currently used to
determine the effects of the medication(s), and c) the kind of additional information that
would be useful in making treatment decisions. Based on your responses, coupled with
similar input from parents/guardians and Van Buren staff, we will arrange to collect and to
report to you data relevant to the effects of psychotropic medication.
Informed consent will be secured from the parent/guardian of each student involved in the
project. The results of the project will be reported in the Doctoral dissertation of Lynne
Turner and may be reported at conferences or in journals. The Human Subjects Institutional
Review Board at Western Michigan University has approved the project. Should you have
questions concerning it, any of the following individuals would be happy to answer them.
Sincerely,
Lynne Turner, M.A.
Research Associate
387-4498

Diane Mosley, MSW
Social Worker
427-4961

Alan Poling, Ph.D.
Professor
387-4483

Kristal Ehrhardt, Ph.D.
Associate Professor
387-4478
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W este rn Michigan University
D epartm ent of Psychology
Principal In v estig ato rs: Alan Poling and Kristal E h rh ard t
R esearch A ssociates: Lynne T urner
T eacher Permission
I have been invited to p articip ate in a re se a rc h p ro jec t en title d
"Monitoring th e Effects of Psychotropic Drugs in Students with Emotional
Impairments: Home and School Data". The purpose o f th e study is to
evaluate how medication is m onitored in th e schools and a t home and to
establish an ongoing monitoring system if one is not currently in place.
This p ro je c t is being conducted to fulfill Lynne T urner’s d isse rta tio n
requirem ents.
This p ro jec t will be conducted in two phases. I a g ree in th e f i r s t phase
to b e interviewed to com plete a b rie f questionnaire th a t includes
questions about (name of child)'s c u rre n t medication and behavior. The
interview will ta k e no m ore th an 20 m inutes to complete. I also a g re e in
th e second phase to monitor stu d e n t behaviors.
The interview responses will be confidential. This means th a t your name
and th e s tu d e n t's name will be om itted from all form s and a code number
will be a tta c h e d . The principal investigator will keep a s e p a ra te m aste r
list with th e names of th e children and th e corresponding code numbers.
Once th e d a ta a re collected and analyzed, th e m aster list will be
d estroyed. All o th e r form s will b e retain ed f o r th r e e y e a rs in a locked
file in th e principal investigator's o ffice. No names will b e used if th e
re su lts a re published o r re p o rte d a t a professional meeting.
I f I chose to participate, I may gain knowledge about th e intended
e f f e c ts o f th e medication th a t my stu d e n t is taking. I will also have th e
opportunity to provide critical feed b ack to th e investigators about
monitoring medication in school settin g s. My feed b ack may fa c ilita te
changes th a t would make such a monitoring system m ore feasib le fo r
te a c h e rs like myself to implement.
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I f I choose to participate, I may find t h a t I am d issa tisfie d with th e
medication my stu d e n t is prescribed. However, it is not th e re se a rc h e rs'
purpose to bring about changes in medication, but to monitor th e e f f e c ts
of prescribed medication.
I am f r e e to term in a te my involvement in th e p ro jec t a t any tim e during
e ith e r phase one or phase two. Doing so will have no negative
consequences or penalties, although, th e r e is a possibility th a t th e
s tu d e n t's p a re n ts may be upset with my decision.
I f I have any questions, I may c o n tact Lynne T urner a t 387 -4 4 9 8 , Kristal
E h rh ard t a t 3 8 7 -4 4 7 8 or Alan Poling a t 387-4483. I may also con tact
th e chair of th e Human S u b je c t In stitu tio n al Review Board a t 387-8 2 9 3
o r th e Vice P resident f o r R esearch a t 3 8 7 -8 2 9 8 with any concerns t h a t I
have.
This permission document has been approved fo r use f o r one y e ar by th e
Human S u b je c ts In stitutional Review Board as indicated by th e stam ped
d a te and signature of th e board chair in th e upper rig h t corner.
S u b je cts should not sign th is docum ent if th e corner does not have a
stam ped d a te and signature

D ate

Time

You a re making a decision w h eth er or not to participate. Your signature
indicates th a t you have decided to p articip ate having read th e
inform ation provided above.

Signature of Parent/G uardian

S ignature o f In v estig a to r
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CD
■D

O
Q.
C
o

CD

Q.

■CDD

Student 1 Data Collection Form

C/)

(/)
Time of Day:
O
■O
D
cq'

■CDD
O
Q.
C
a
o

■o
o

CD

Q.

■CDD
C/)
C/)

Sent to time-out booth? Y / N

Activity Occurring at Time of Request
□ Math
□ English
a Reading
□ Spelling
a History
□ Other

Type of Instruction
□ Independent Seatwork
□ Lecture
□ Group Work
□ Other

Calmed by self? Y / N

Type of Behavior
□
Aggression
□
Other

Appendix G
Student 2 Data Collection Form I
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Student 2 Data Collection Form I
Date

Time

Coding Key:
Behavior
IL = Inappropriate Language
IC = Inappropriate Crying
TS = Talldng about suicide
SIB = Harming self by bitting self,
scratching skin or pulling hair
O = Other behavior (please specify)

Behavior

Activity

Type o f
Instruction

Type of
Instruction
Activitv
IS = Independent
M = Math
Seatwork
S - Spelling
L = Lecture
R = Reading
GW = Group Work
SS = Social Studies
O = Other
L = Language
PE = Physical Ed
AE = Affective Ed
O = Other (please specify)
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CD
■D

O
Q.
C
o
CD

Q.

■CDD

Student 2 Data Collection Form II
Requesting to leave class

C/)

(/)
Time of Day:

Permitted to leave class? Y / N

Time returned:

O
■O
D
cq

'

O
Q’
■CDD
O
Q.
C
a

Activitv Occurring at Time of Request
a Math
□ Language
□ Reading
□ Spelling
a Social Studies
□ PE
□ Affective Ed.
□ Other:

Tvpe of Instruction
□ Independent Seatwork
a Lecture
□ Group Work
□ Other

Tvne of Request
□
To see SSW
□
Other

o

■o
o

CD
Q.

■CDD
(/)
(/)

V
O
Lh

Appendix I
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Student 3 Data Collection Form
Date

Time

Coding Key:
Behavior
ST = Stealing
L = Lying
TB = Talking back to teacher
O = Other Behavior (please specify)

Behavior

Activity

Activitv
M = Math
S = Spelling
R = Reading
SS = Social Studies
L = Language
PE = Physical Ed
AE = Affective Ed
O = Other (please specify)

Type o f
Instruction

Type of
Instruction
IS = Independent
Seatwork
GW = Group Work
0 = Other
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Student 4 Data Collection Form
Time

Check one
w
FS
R

SS

Activity

INSTRUCTION

IS

GW

8:00 - 8:15
8:15 - 8:30
8:30 - 8:45
8:45 - 9:00
9:00 - 9:15
9:15 - 9:30
9:30 - 9:45
9:45 - 10:00
10:00 - 10:15
10:15 - 10:30
10:30 - 10:45
10:45 - 11:00
11:00 - 11:15
11:15 -11:30
11:30 - 11:45
11:45 - 12:00
12:00 - 12:15
12:15 - 12:30
12:30 - 12:45
12:45 - 1:00
1:00 - 1:15
1:15 - 1:30
1:30 -1:45
1:45 - 2:00
2:00 - 2:15
2:15-2:30

Coding Key:
Behavior
R = Rocking Self
W = Wringing hands
FS = Failure to start a
task when given a prompt
SS = Sitting at desk playing
with an object or self

entertainment

Activitv
M = Math
R = Reading
PE = Phys. Ed.
LU = Lunch
L = Language
SS = Social Studies
AM = Mom Routine
PM = Afternoon Routine
ED = End of day Routine
E = Level Eval.

Instmction
IS = Independent Seatwork
GW = Groupwork
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CD
■D

O
Q.
C
o
CD

Q.

■CDD

Student 5 Data Collection Form

C/)

(/)
Time of Day;
O
■O
D
cq

'

O
’
CD
■CDD
O
Q.
C
a
o

■o
o

CD

Q.

■CDD
(/)
(/)

Sent to time-out booth? Y / N

Behavior
a Property Destruction
□ Requesting to leave class to sleep
a Amount of time asleep:
□ Refusal to follow directions
□ Talking back to teacher (swearing)
a Other

Activitv Occurring
□ Math
□ English
□ Reading
□ Spelling
□ History
□ Other

Calmed by self? Y / N

Tvpe of Instruction
Independent Seatwork
□
□
Lecture
□
Group Work
a Other

Appendix L
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CD
■D

O
Q.
C
o
CD

Q.

■CDD
C/)

(/)

Parent/Guardian:__________

Child's Name:
Med I

O
■O
D
cq

'

O
Q’
■CDD
O
Q .
C
a
o

■o

Med II

Med III

Med IV

Med V

Is your child currently taking medication
to improve his/her behavior?
How much of this medication does
your child take each day and when?
Do you know the potential side effects
for this medication? YES or NO
If yes, please indicate.
It is not unusual for children to miss a
dosage of med. Is this ever a problem
for your family.
Do you ever give your child the med.
different from how it is stated on the
bottle?

o

Does your child have a psychiatric diagnosis? YES NO

CD
Q .

Is a medication prescribed to deal with this condition? YES NO If yes, please indicate:
If yes, please indicate if the medication is prescribed to deal with the following: (Go to page 2)

■CDD
(/)
(/)

Overall, how satisfied are you with the results produced by the medication(s) listed above?
C3 I am very satisfied
d 1am somewhat satisfied
d I am not at all satisfied

o

CD
■D

O
Q.
C
o
CD

Q.

■CDD
W as a medication

C/)

(/)

Kind of Behavior
O
■O
D
cq

'

O
Q’
■CDD
O
Q .
C
a
o

■o
o

I. Conduct Problem

■CDD
(/)
(/)

How satisfied are you

track of this

with the results produced

of behavior?

present time?

behavior?

by the medication?

YES NO DK

YES NO DK

YES

NO

□ I am very satisfied
□ I am somewhat satisfied
□ I am not at all satisfied

YES NO DKi YES NO DK

YES

NO

; □ I am very satisfied
□ i am somewhat satisfied
CH i am not at ail satisfied

YES NO DK i YES

NO

□ I am very satisfied
□ I am somewhat satisfied
□ I am not at ail satisfied

Examples of such behavior include, but are not limited to;

Agruing with parents, teachers or other adults
Threatening people
Being defiant or chailenging adult authority
Knowingly destroys property

II. Insecure/Anxious
Examples of such behavior include, but are not limited to:

Overly sensitive or feelings easily hurt
Exaggerating abilities or acheivements
Feelings easily hurt
Overly anxious to please others
Feeling worthless or inferior

III. Hyperactive
CD
Q .

is this kind of behavior
a problem at the

Are you keeping

with this kind

prescribed to deal

Examples of such behavior include, but are not limited to:

Failing to finish things s/he starts
Fidgetting, wiggling, orsquirmming
Being overactive or not sitting still
Beina overly excited or exuberant

YES NO DK

CD
■D

O
Q.
C
o
CD

Q.

■CDD
W as a medication

C/)

(/)

prescribed to deal
with this kind

O
■O
D
cq

'

O
Q’
■CDD
O
Q .
C
a
o

■o
o
CD
Q .

■CDD

How satisfied are you

is this kind of behavior j Are you keeping
a problem at the
|
track of this

of behavior?

present time?

|

YES NO DK

YES NO DK

YES

YES NO DK

YES NO DK

I YES

YES NO DK

YES NO DK

YES

with the results produced
by the medication?

behavior?

Kind of Behavior
IV. Sef-tniurv/Sterotvpic

NO

□ I am very satisfied
□ I am somewhat satisfied
□ 1am not at all satisfied

Examples of such behavior include, but are not limited to:

Physically hurting self on purpose
Hitting or slapping self
Harming self by scratching skin or pulling hair
Gouging self, putting things in ears, nose, etc
or eating inedible items
Rocking body or head back and forth repetitively

V. Self-lsolated/Rltualistic

NQi

I am very satisfied
i □ I am somewhat satisfied
□ i am not at ail satisfied

Examples of such behavior include, but are not limited to:

Isolating self from others
Being secretive or keeping things to self
Refusing to talk
Having rituals such as head rolling or floor pacing
Having odd repetitive behaviors (staring, grimacing)

VI. Overly Sensitive
Crying or tearful episodes
Feelings easily hurt

NO

I □ I am very satisfied
O I am somewhat satisfied
□ i am not at ail satisfied

(/)
(/)

o
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CD
■D

O
Q.
C
o
CD

Q.

■CDD
C/)

W
o'
o

Student's Name:

o

Med t

Med It

Med III

Med IV

Med V

Is this student currently taking medication

o
o

■D
cq

Teacher:

to improve his/her behavior?

'

Do you know the potential side effects

O
o’
■CDD
O
Q .
c
a
o
Q
■O

for this medication? YES or NO
If yes, what are they?
Are you systematically monitoring
potential side effects?

Does this student have a psychiatric diagnosis? YES NO
Is a medication prescribed to deal with this condition? YES NO If yes, please indicate:

o

If yes, please indicate if the medication is prescribed to deal with the following: (Go to Child Behavior Interview Form)
CD
Q .

■CDD

Overall, how satisfied are you with the results produced by the medication(s) listed above?
n I am very satisfied
n I am somewhat satisfied
a I am not at all satisfied

(/)
(/)

o

'J

CD
■D

O
Q.
C
o
CD

Q.

■CDD
W as a medication

C/)

(/)

Kind of Behavior
O
■O
D
cq

'

O
Q’
■CDD
O
Q .
C
a
o

■o
o

I. Conduct Problem

■CDD

is this kind of behavior
a problem at the

Are you keeping

How satisfied are you

track of this

with the results produced

of behavior?

present time?

behavior?

by the medication?

YES NO DK 1 YES NO DK

YES

NO

YES

N O i □ I am very satisfied

Examples of such behavior include, but are not limited to:

Agruing with parents, teachers or other adults
Threatening people
Being defiant or challenging adult authority
Knowingly destroys property
Getting into physical fights

II. Insecure/Anxious

YES NO DK

YES NO DK

O I am somewhat satisfied
□ I am not at all satisfied

Overly sensitive or feelings easily hurt
Exaggerating abilities or acheivements
Feelings easily hurt
Overly anxious to please others
Feeling worthless or inferior
Examples of such behavior include, but are not limited to:
Failing to finish things s/he starts
Fidgetting, wiggling, orsquirmming
Being overactive or not sitting stilt
Being overly excited or exuberant

Q 1am very satisfied
□ 1am somewhat satisfied
□ 1am not at all satisfied

1

Examples of such behavior include, but are not limited to:

III. Hyperactive
CD
Q .

presCTibed to deal
with this kind

YES NO DK

YES NO DK

YES

NO

□ I am very satisfied
□ I am somewhat satisfied
□ I am not at all satisfied

(/)
(/)

o
oo

CD
■D

O
Q.
C
o
CD

Q.

■CDD
W as a medication

C/)

(/)

O
■O
D
cq

'

O
Q’
■CDD
O
Q .
C
a
o

■o
o

CD
Q .

Kind of Behavior

(/)
(/)

How satisfied are you

track of this

with the results produced

of behavior?

present time?

behavior?

by the medication?

YES NO DK I YES NO DK | YES

NO . °

IV. Sef-lniurv/Sterofvpic

i

I

Examples of such behavior include, but are not limited to:
Physically hurting self on purpose
Hitting or slapping self
Harming self by scratching skin or pulling hair
Gouging self, putting things in ears, nose, etc
or eating inedible items
Rocking body or head back and forth repetitively

V. Self-Isolated/Ritualistic

NO

□ I am very satisfied
□ I am somewhat satisfied
□ I am not at all satisfied

YES NO DK i YES NO DK I YES

NO

□ I am very satisfied
O I am somewhat satisfied
□ 1am not at all satisfied

Isolating self from others
Being secretive or keeping things to self
Refusing to talk
Having rituals such as head rolling or floor pacing
Having odd repetitive behaviors (staring, ghmacinc

VI. Irritable
Crying or tearful episodes
Easily frustrated
Being explosive or easily angered
Having a sudden change in mood

am very satisfied
I am somewhat satisfied
d I am not at all satisfied

YES NO DK I YES NO DK ! YES

Examples of such behavior include, but are not limited to:

Examples of such behavior include, but are not limited to:

■CDD

Is this kind of behavior
a problem at the

Are you keeping

with this kind

prescribed to deal
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Ill
Date:

Child’s Name:
Physician:____
1. Does this child have a psychiatric diagnosis? YES or NO
If yes, please indicate: ________________________
2. Is medication prescribed to treat the psychiatric condition? YES or NO
If so, what medication(s)?_____________________________
3. Are you receiving information about the severity of the psychiatric condition?
YES or NO
If so, how?
4. Is medication prescribed to deal with behaviors not indicative of a psychiatric
condition? YES or NO
If so, what are the problematic behaviors?

If so, what medications?

5. Are you receiving information about the severity of the problematic
behaviors? YES or NO
If so, how? _______ ______ ________ ___________________ ________
6. Would you like to receive additional information relevant to the effects of the
psychotropic medication(s) prescribed for this student? YES or NO
If so, what kind of information?
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TME MSC»N<SE1? <1:111 V m w i c ^ "ROTNiGTCIRH
PARENT VERSION

Child's Name:

]

Child's Date o f Birth:

/
month

Rater's Name:

Date o f Ratine:

/
month

Relation o f Rater to Child: O parent [1]

/
day

year

/
day

year

O other f91:
(please specify)

I.

Please describe any special circumstances or mediating factors that may have affected the child's
behavior in the recent past (the last month or two) or prevented you from making complete ratings.

II. POSITIVE SOCIAL. Please describe the child's behavior as it was at home over the last month.
Not
Trae
[0]

Somewhat
or
Sometimes
Tme
[1]

Very or
Often Tme
[2]

Completely
or Always
Tme
[3]

1. Accepted redirection

a

□

□

□

2. Expressed ideas clearly

□

a

□

a

3. Followed rules

□

□

□
□

□

In

th e l a s t m o n t h , th is c h il d h a s :

a

a
□
□

□

7. Shared with or helped others

□
□
□

a

□

a

8. Stayed on task

□

□

a
a

a
a
a

□

a

4. Initiated positive interactions
5. Participated in group activities
6. Resisted provocation, was tolerant

9. Was cheerful or happy
10. Was patient, able to delay

□

a

P age 1
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a
□

□

a
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Nisonger CBRF: Parent
III. PROBLEM BEHAVIOR. For each item that describes the child's behavior as it was over the last month,
circle the:
0... .if the behavior did not occur or was not a problem
1.... if the behavior occurred occasionally or was a mild problem
2 .... if the behavior occurred quite often or was a moderate problem
3.... if the behavior occurred a lot or was a severe problem

For each problem that occurred, circle only the score that best describes the behavior.
P l e a s e d o n o t sk ip a n y q u e s tio n s . I f y o u d o n o t k n o w t h e a n s w e r o r h a v e n o t h a d a c h a n c e t o
OBSERVE THE CHILD FOR A GIVEN TIME, CIRCLE THE ZERO.

1. Apathetic or unmotivated............................. ...
2. Argues with parents, teachers, or
other adults.................................................. ...
3. Clings to adults, too dependent................... ...
4. Cruelty or meanness to others..................... ...
5. Crying, tearfiil episodes............................... ...
6. Hits or slaps own head, neck, hands.
or other body parts....................................... ...
7. Defiant, challenges adult authority.............. ...
8. Knowingly destroys property............. ......... ...
9. Difficulty concentrating............................... ...
10. Disobedient................................................. ...
11. Rocks body or head back and forth
repetitively................................................... ...
12. Doesn't feel guilty after misbehaving.......... ...
13. Easily distracted........................................... ...
14. Easily fhistrated........................................... ...
15. Overly sensitive; feelings easily hurt........... ...
16. Exaggerates abilities or achievements........ ...
17. Explosive, easily angered............................ ...
18. Has rituals such as head rolling or
floor pacing................................................. ...
19. Fails to finish things he/she starts............... ...
20. Feelings easily hurt...................................... ...
21. Feels others are against him/her.................. ...
22. Harms self by scratching skin or
pulling hair.................................................. ...
23. Feels worthless or inferior............................ ...
24. Fidgets, wiggles, or squirms....................... ...
25. Shy around others; bashfiil........................... ...
26. Gets in physical fights.................................. ...
27. Irritable........................................................ ...
28. Repeatedly flaps or waves hands, fingers
or objects (such as pieces of string)............ ...
29. Isolates self fi-om others.............................. ...
30. Lying or cheating........................................
31. Nervous or tense......................................... ...
32. Gouges self) puts things in ears, nose.
etc., or eats inedible things.......................... ...
33. Overactive, doesn't sit still..........................

1

2

3

1
1
1
1

2
2
2
2

3
3
3
3

1
I
1
I
1

2
2
2
2
2

3
3
3
3
3

1
1
I
1
1
1
1

2
2
2
2
2
2
2

3
3
3
3
3
3
3

34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.

1
1
1
1

2
2
2
2

3
3
3
3

50.
51.
52.
53.

1
1
1
1
1
1

2
2
2
2
2
2

3
3
3
3
3
3

54.

1
1

2
2

1

2

3
3
3
3

1
I

2
2

3
3

55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.

Overly anxious to please others....................... .....
Overly excited, exuberant............................... .....
Physically attacks people................................ .....
Refuses to talk............................................... .....
Repeats the same sound, word, or
phrase over and over....................................... .....
Restless, high energy level.............................. .....
Runs away from adults, teachers, or
other authority figures.................................... .....
Says no one likes him/her.............................. .....
Secretive, keeps things to self......................... .....
Repeatedly bites self hard enough to
leave tooth marks or break skin....................... .....
Self-conscious or easily embarrassed............. .....
Shifts rapidly from topic to topic
when talking................................................... .....
Short attention span....................................... .....
Shy or timid behavior.................................... .....
Steals............................................................. .....
Odd repetitive behaviors (e.g., stares.
grimaces, rigid postures)................................. .....
Stubborn, has to do things own way............... .....
Sudden changes in mood................................ .....
Sulks, is silent and moody.............................. .....
Physically hanns or hurts self on
purpose.......................................................... .....
Talks back to teacher, parents, or
other adults.................................................... .....
Talks too much or too loud............................. .....
Temper tantrums............................................ .....
Threatens people............................................ .....
Threatens to harm self................................... .....
Engages in meaningless, repetitive
body movements............................................ .....
Too fearful or anxious.................................... .....
Undeiactivc, slow.......................................... .....
Unhappy or sad.............................................. .....
Violates rules................................................. .....
Withdrawn, uninvolved with others............... .....
Worrying.......................................................
Argues with other children or peers............... .....

mm
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1
1
1

2
2
2
2

1
1

2
2

1
1
1

2
2
2

1
1

2
2

I
1
1
1

2
2
2
2

1
1
1
1

2
2
2
2

1

2

1
1
1
1
1

2
2
2
2
2

1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
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... ' ■■■"" ...... ................................
Detection Of Side Effects Scale
(DOSES)-Family

Individual's Name

Date

Person Completing Scale

120
Rating Type (ciwck a

Scoring

instntciions: See other side for details.
.:
1. Circle score for each Hent.
2. Base score upon last 7 days:
3. Indicate if Hem Is new, diffenmt. or more severe for die indiyidiial.

3: Very Much
NA: Not Assessat)le

0: Not at AR
1: AUttle
2; Pretty Mudi

□ nequested by Health
Professional
□ Family Iniliafed

Item and Score
1.

Bad Dreams/Nightmares ---------

—

2 . Bowel Movements: O more (diarrhea)

3. Clumsy/Poor Balance/Stumbling---------

Yes

- 0

1

2

3

NA

New/More Severe:

0

1

2

3

NA

New/More Severe:

Yes

• 0

1

2

3

NA

New/More Severe:

Yes
Yes

□ less (constipation) -----

4. Crying —----------------- --------------------

•

0

1

2

3

NA

New/More Severe:

5. Dizziness/Fainting (upon standing? □ yes □ n o)-----

•• 0

1

2

3

NA

New/More Severe:

Yes

Q less --------------- ---------------

.. 0

1

2

3

NA

New/More Severe:

Yes

6.

Drinking: Q more

7.

Eating: i:}more

Q less ...............-...................- ....—

.. 0

1

2

3

NA

NewMore Severe:

Vfes

8 . Excessive Energy/Constantly On The Go ----------------

■0

1

2

3

NA

Yes

9. Headache------------------------------------------- -----------

2
2

3

NA

Nev/More Severe:
New/More Severe:

3

NA

New/More Severe:

Yes

NA

New/More Severe:

Yes

NA

New/More Severe:

Yes

- 0

1

---------------— ------- -~-

• 0

1

11 . irritable/Gets Angry Easily ......— ............... -...... —

• 0

2
2

3
3

10. Itchy/Scratchy Skin

Yes

□ tics/Jerky .

. 0

1
1

13. Rash/Hives
.....................
- ....
14. Sad/Not Happy/Seems More Serious------------------

- 0

1

2

3

NA

New/More Severe:

Yes

• 0

1.
1

2

3

Yes

3

NA
NA

NewMore Severe:

2

New/More Severe:

0

1

2

3

NA

New/More Severe:

Yes
Yes

1

0

1

2

3

NA

New/More Severe:

Yes

1

12 .

Muscles: □ cramps

□ pain

□ stiff

15. Saliva: O more (pooling/drooling) □ less (dry mouth/I^) •—
16. Seizures/Convulsions ------------------------------------------------17. Sfiakiness/Tremor: □ hands

□ otfier (descritie in Other) ■

18. Sick to Stomach: □ nausea

Q vomiting --------------------

~ 0

0

1

2

3

NA

New/More Severe:

Yes

□ less □ trouble getting to sleep

• 0

1

2

3

NA

New/More Severe:

Yes

20. Speech: Slurred/Harder to Understand --------------------

• 0

1

3

NA

New/More Severe:

Yes

21. Stomach: Acfies/Discomfort/Hearttxjm ---------------------

■0

1

2
2

3

NA

New/More Severe:

Yes

22 . Stuffy Nose/Runny Nose/Congestion -----------------------

- 0

1

2

3

NA

New/More Severe:

Vbs

23. Sunlxims Easily------------------------------------ ---------- 24. Sweating: Qmore O le s s
----------- -------------- ---

1

2

3

NA

New/More Severe:

Yes

• 0

1

2

3

NA

New/More Severe:

Yes

25. Tired/Feeling Sleepy/Decreased Energy

-------------------------

• 0

1

2

3

NA

New/More Severe:

Ybs

26. Troutile CorKentrating/Difflculty Paying Attention---------------27. Tiouble Doing Things with Hands/Less Steady Using Hantfe —
28. Trout)le Getting Along with Staff/Hard to P lea se
-----------

" 0

1

2

3

NA

New/More Severe:

yes

1

- 0

1

2

3

/

2

3

Vbs

1

29. Troutile Getting Along with Other Clients---------------------------

- 0

1
1

New/More Severe:
New/More Severe:

Vbs

- 0

NA
NA

2

3

NA

New/More Severe:

Yes

i

30. Trouble Performing Usual Activities or Playing Sports--------------

- 0

1

2

3

NA

New/More Severe:

Yss

1

31. Trouble Seeing: □ blurred □ doutrle □ spots □ colors-------

. 0

1

2

3

NA

New/More Severe:

Yes

32. Trouble Sitting StilVJittery--------------------------- ---------------------

- 0

1

2

3

NA

NewMore Severe:

Yes

19. Sleeping:

□ more

1

1

• 0

1

2

3

NA

NewMora Severe:

Yes

34. Unusual Skin Temperature: □cold Qliot/lever
35. Urination: Qmore D less □ delayed Opainlul

- 0

1

2

3

NA

NewMore Severe:

Yes

1

■n

2

3

NA

NewMore Severe:

Vfes

1

36. Urination: Bedwetting------------------------------------------

- 0
.. 0

1
1

2

3

NA

NewMore Severe:

Vhs

>

1

2

3

NA

NewMore Severe:

Yes

1

33. Unusual Skin Colon Qtiiue

Qfhisli/red

□ pallor QyeBow-

37. WitlidrawnTTalks L e s s -----------------------------------------
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other Unusual Signs/Symptoms (specify):

Comments:

Instructions:
1. It is critical to dmect side effects associated with psychotropic and antiepileptic medication. One important step Is for the people wh
Hve ynth or work with the poison to report anything unusual to the health care professional.
2. Complete the scale on the date requested by the health care professional. Hyou wish,-you may also complete the scale onyour ovr
or it you notice something unusual. Please remember tt^ Is not a replacement for immediately c o n t a c t the health care piolessio
when a senous, pronounced, or emergency situation occurs.
3. petermine tlfo score for each item based upon ttie past week (7 days). Over the past weeir, did you observe or notico any ot ttie
. Hems? if ttuj. person is Verbal, did tie or she complain alxiut any of ttie items?
4. Select ttie sc<^
e i ^ illm based u | ^ what you actually see or wtiat the person teffs you. Od not ^riote’tlfo' Item tiecause you
*kr^tlie person': ,par example, the pensbn may constantly drool due to a Jaw ifeformtty. Because ft ooiursfrerjueritly, it would be
srfored "very much*. Whether the drooBng is different from what the person typically does is determined in the riext step (In this cast
IS not)
■■ ■■
5. Determine as liest as you can It,the sign, or symptom is different from what ttie person normally does, is.iksually Oke, has always do
or h a s ^ a y s t i^ a prpbfomylifih.Tfie folloviihg considerations m ^ help. Quantitatively: Is k srxnethfog not seen before? Is It mor
frequent fhsm usual? Did he/she do it this m u^ before? Is Hmore severe than before? Is it more Intense than usual? Are we nolicir
it more lately? Are we (myirig aiot mdre.attenlian to W Are we spending a lot more time with H? Quatitatiy^: It never looked like t
bekMe. lt iobks:diflSietd.’7liere
UtSiiSual alwut it Sornethlng's not right. HetShe is riot NmseMftforsmJ It Mnd ot worries rr
6. t^rchrkfe'the scliete thh heStth r»iB prdfossiori^.
■■

.

.

.

.

.

-

7. f^lease note n u ^ Rems ate M^diiedause n K ^ dW
of medication are used wRh m ^ tfifferent people. Not aU pi the
. Rents ate caused by tIib'InpiiPatiOl)
remember Just, because ah Rem is s c r ^ ddes'htR necessary mean
Is a Skte bftecl. &>ine ottwr faUPr rhay tfo'RivdlvM Yhe goal ai this point is to systematically report ahyMng uritsiial to ttie IteaRh
care prol^iond so Rcaih t>e checked artd, Rnecessary, reviewed 1^ the piescrilier arid pharmacist. .' . '

_ ..

W f K lw tt y »>»«■» «Wi I fctti. fi$yehofih$ m teolagrOi^lelk»,9-04fp»d^^»f»}.

_

Qiiatmn, H. (unknomn

lNaae^itnM m eonipm»m» igot9MpM[i(mmfianm 0nigmmmnaor99BclsmfdtinatmsUbstlM6k
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Acceptability Survey - Parent
Purpose:
•
Because the medication monitoring system is a “work in progress,” we will ask you to
evaluate it several times. Your feedback will enable iis to improve the monitoring
procediues. These improvements will not only ensure better monitoring o f the
student’s behaviors, but they will also guarantee a more practical and acceptable
system for teachers and parents who already have substantial workloads.
Directions:
•
Below are a few short questions about the Child Behavior Rating Form (CBRF) and the
Detection o f Side Effect Scale (DOSES). Please fill in the blanks or check the item
that best matches your opinion.

1.

Are any o f the behaviors listed (items 1 - 66) on the CBRF unclear or difficult to understand?
□ YES (if yes, please list items below)
□ NO

2.

In yoiff opinion, how satisfactory is the CBRF as an instrument for assessing troublesome
behavior for children with emotional impairments?
□ Very satisfactory (skip to question # 4)
□ Somewhat satisfactory (see question # 3)
O Not very satisfactory (see question # 3)
□ Not at all satisfactory (see question # 3)

3.

Why do you feel that the CBRF is in some way imsatisfactory?

4.

Are the directions for the DOSES easy to understand?
□ YES
n NO (if no, please explain in the space below)
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5.

Are any o f the side effects (items 1 - 37) on the DOSES imclear or difficult to imderstand?
□ YES (if yes, please list items below)
□ NO

6.

In your opinion, how satisfactory is the DOSES as an instrument to detect side effect in children
with emotional impairments?
□ Very satisfactory (skip to question # 8)
□ Somewhat satisfactoiy (see question # 7)
□ Not very satisfactory (see question # 7)
□ Not at all satisfactory (see question # 7)

7.

Why do you feel that the DOSES is in some way unsatisfactory?
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Acceptability Survey - Teacher
Purpose:
• Because the medication monitoring system is a “work in progress,” we will ask you to
evaluate it several times. Your feedback will enable us to improve the monitoring
procedures. These improvements will not only ensure better monitoring o f the
student’s behaviors, but they will also guarantee a more practical and acceptable
system for teachers and parents who already have substantial workloads.
Directions:
• Below are a few short questions about the Child Behavior Rating Form (CBRF) and the
Detection o f Side Effect Scale (DOSES). Please fill in the blanks or check the item
that best matches your opinion.

1.

Are any o f the behaviors listed (hems 1 - 66) on the CBRF unclear or difficult to understand?
□ YES (if yes, please list items below)
□ NO

2.

In your opinion, how satisfactory is the CBRF as an instrument for assessing troublesome
behavior for children with emotional impairments?
□ Very satisfactory (skip to question # 4)
□ Somewhat satisfactory (see question # 3)
□ Not very satisfactory (see question # 3)
ni Not at all satisfactory (see question # 3 )

3.

Why do you feel that the CBRF is in some way unsatisfactory?

4.

Are the directions for the DOSES easy to understand?
□ YES
□ NO (if no, please explain in the space below)
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5.

Are any o f the side effects (items 1 - 37) on the DOSES unclear or difficult to imderstand?
□ YES (if yes, please list items below)
□ NO

6.

In your opinion, how satisfactory is the DOSES as an instrument to detect side effect in children
with emotional impairments?
n Very satisfactory (skip to question # 8)
□ Somewhat satisfactory (see question # 7)
□ Not very satisfactory (see question # 7)
□ Not at all satisfactory (see question # 7)

7.

Why do you feel that the DOSES is in some way unsatisfactory?

8.

For one student, how feasible is it for you to complete the two checklists (the CBRF & the
DOSES) each month?
□ Very feasible
□ Somewhat feasible
n Not very feasible
□ Not at all feasible

9.

Considering your multiple obligations as a teacher, how many students could you rate with the
CBRF and with the DOSES on a monthly basis?
n Very feasible
□ Somewhat feasible
□ Not very feasible
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Parent/Guardian Acceptability Survey Results

Are any o f the behaviors listed (items 1-66) on the CBRF unclear or difficult to
understand?
Number of responses

0 Yes
3 No
In your opinion, how satisfactory is the CBRF as an instrumentfor assessing troublesome
behavior?
Number of responses

3
0
0
0

Very satisfactory
Somewhat Satisfactory
Not very satisfactory
Not at all satisfactory

Are the directions for the DOSES easy to understand?
Number of responses

3 Yes
0 No
Are any o f the side effects (items 1-37) on the DOSES unclear or difficult to understand?
Number o f responses

0 Yes
3 No
In your opinion, how satisfactory is the DOSES as an instrument to detect side effect in
children with emotional impairments?
Number of responses

3
0
0
0

Very satisfactory
Somewhat Satisfactory
Not very satisfactory
Not at all satisfactory
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Teacher Acceptability Survey Results
Are any o f the behaviors listed (items 1-66) on the CBRF unclear or difficult to
understand?
Number of responses

1 Yes
4 No
Comments:

•

Gets in physical fights #26 - How physical is physical? / #28 and #49

In your opinion, how satisfactory is the CBRF as an instrument for assessing troublesome
behavior?
Nnmber o f responses

2
3
0
0

Very satisfactory
Somewhat Satisfactory
Not very satisfactory
Not at all satisfactory

Why do you fee that the CBRF is in some way unsatisfactory/
Comments:

•
•

Some behaviors are not on here but I can’t remember
Difficult to do ratings at times - if behavior occurred one time would we circle a “0”
o r a ‘T ”?

Are the directions for the DOSES easy to understand?
Number of responses

4 Yes
1 No
Comments:

•

I do not understand fully how to rate behaviors given the terms - a little, pretty
much, and very much. A little confusing.

Are any o f the side effects (items 1 - 3 7 ) on the DOSES unclear or difficult to
understand?
Number o f responses

1 Yes
4 No
Comments:

•

Sometimes confusing on “0” and N A
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In your opinion, how satisfactory is the DOSES as an instrument to detect side effect in
children with emotional impairments?
Number of responses

4
1
0
0

Very satisfactory
Somewhat Satisfactory
Not very satisfactory
Not at all satisfactory

Why so you feel that the DOSES is in some way unsatisfactory?
Comments:

•

It would be more satisfaetory if the rating was more understandable.

For one student, how feasible is it for you to complete the two checklists (the CBRF & the
DOSES) each month?
Number of responses

5
0
0
0

Very feasible
Somewhat feasible
Not very feasible
Not at all feasible

Considering your multiple obligations as a teacher, how many students could you rate
with the CBRF and with the DOSES on a monthly basis?
Number o f responses

0
1
0
4
0

0 students
1 student
2 students
3 students
4 students

Comments:

•

Depends on the caseload.
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’ v i l J T LKN

: ■ -^-VERSITY
Human Subjects I n s titu tio n a ^ ^ ie w Board

**Centennial
1903-2003Celebration

Date;

February 20, 2004

To:

Alan Poling, Principal Investigator
Lynne Turner, Student Investigator for dissertation

From: Mary Lagerwey, Ph.D., Chair
Re:

f^\

HSIRB Project Number: 04-02-13

This letter w ill serve as confirmation that your research project entitled “Monitoring the
Effects o f Psychotropic Drugs in Students with Emotional Impairments: Home and
School Data - Analysis o f Data gathered under project 01-01-13” has been approved
under the expedited category o f review by the Human Subjects Institutional Review
Board. The conditions and duration o f this approval are specified in the Policies o f
Western Michigan University. You may now begin to implement the research as
described in the application.
Please note that you may only conduct this researchexactly in theform it was approved.
You must seek specific board approval for any changes in this project.You must also
seek reapproval if the project extends beyond the termination date noted below. In
addition if there are any unanticipated adverse reactions or unanticipated events
associated with the conduct o f this research, you should immediately suspend the project
and contact the Chair o f the HSIRB for consultation.
The Board wishes you success in the pursuit o f your research goals.

Approval Termination:

February 20, 2005

W alwood Hall, K alam azoo,

Ml49008-5456

PHONE: (269) 387-8293 FAX: (269) 387-8276
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